#BEGIN_DRUGCARD DB03317

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
60562

# Chemical_Formula:
C34H34FeN4O4

# Chemical_IUPAC_Name:
3-[(1S,10Z,15Z)-20-(2-carboxyethyl)-10,15-diethylidene-5,9,14,19-tetramethyl-2,22,23,25-tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-3(24),4,6,8,11,13,16,18,20-nonaen-4-yl]propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Heme C

# HET_ID:
HEC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C34H34N4O4.Fe/c1-7-21-17(3)25-13-26-19(5)23(9-11-33(39)40)31(37-26)16-32-24(10-12-34(41)42)20(6)28(38-32)15-30-22(8-2)18(4)27(36-30)14-29(21)35-25;/h7-8,13-16H,9-12H2,1-6H3,(H,39,40)(H,41,42);/q-4;+4/b21-7-,22-8-,26-13-,29-14-,30-15-,31-16-;

# InChI_Key:
InChIKey=HXQIYSLZKNYNMH-STIJKOADSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3317

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
618.503

# Molecular_Weight_Mono:
618.192947729

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1H29

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
4.28

# Predicted_LogS:
-2.8

# Predicted_Water_Solubility:
9.40e-01 g/l

# Primary_Accession_No:
DB03317

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936638

# PubChem_Substance_ID:
46508322

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01722

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C\C=C1\C(C)=C2C=C3N4C(=CC5=C(CCC(O)=O)C(C)=C6C=C7N8C(C=C1N2[Fe@]48N56)=C(C)\C7=C\C)C(CCC(O)=O)=C3C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:08 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Endoplasmic reticulum

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
Not Available

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
CYP2C9

# Drug_Target_10_GenBank_ID_Gene:
AY341248

# Drug_Target_10_GenBank_ID_Protein:
Not Available

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
CYP2C9

# Drug_Target_10_Gene_Sequence:
>1473 bp
ATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG
AGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA
AATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC
TATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT
GAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC
CCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG
AAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC
ATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG
GCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC
ATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG
TTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT
CCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG
AAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT
CAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT
GAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG
ACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA
GCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA
GACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC
CTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC
ATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA
TTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG
AAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG
GCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT
CTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG
CCCTTCTACCAGCTGTGCTTCATTCCTGTCTGA

# Drug_Target_10_General_Function:
Involved in monooxygenase activity

# Drug_Target_10_General_References:
1445376	Ohgiya S, Komori M, Ohi H, Shiramatsu K, Shinriki N, Kamataki T: Six-base deletion occurring in messages of human cytochrome P-450 in the CYP2C subfamily results in reduction of tolbutamide hydroxylase activity. Biochem Int. 1992 Sep;27(6):1073-81.
1857342	Srivastava PK, Yun CH, Beaune PH, Ged C, Guengerich FP: Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Mol Pharmacol. 1991 Jul;40(1):69-79.
2827463	Meehan RR, Gosden JR, Rout D, Hastie ND, Friedberg T, Adesnik M, Buckland R, van Heyningen V, Fletcher J, Spurr NK, et al.: Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. Am J Hum Genet. 1988 Jan;42(1):26-37.
2963808	Yasumori T, Kawano S, Nagata K, Shimada M, Yamazoe Y, Kato R: Nucleotide sequence of a human liver cytochrome P-450 related to the rat male specific form. J Biochem. 1987 Nov;102(5):1075-82.
3032244	Umbenhauer DR, Martin MV, Lloyd RS, Guengerich FP: Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1987 Feb 24;26(4):1094-9.
3079764	Shimada T, Misono KS, Guengerich FP: Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J Biol Chem. 1986 Jan 15;261(2):909-21.
3196692	Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, Guengerich FP: Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. Biochemistry. 1988 Sep 6;27(18):6929-40.
3243766	Komori M, Hashizume T, Ohi H, Miura T, Kitada M, Nagashima K, Kamataki T: Cytochrome P-450 in human liver microsomes: high-performance liquid chromatographic isolation of three forms and their characterization. J Biochem. 1988 Dec;104(6):912-6.
3697070	Kimura S, Pastewka J, Gelboin HV, Gonzalez FJ: cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. Nucleic Acids Res. 1987 Dec 10;15(23):10053-4.

# Drug_Target_10_HGNC_ID:
HGNC:2623

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
4757

# Drug_Target_10_Locus:
10q24

# Drug_Target_10_Molecular_Weight:
55629

# Drug_Target_10_Name:
Cytochrome P450 2C9

# Drug_Target_10_Number_of_Residues:
490

# Drug_Target_10_PDB_ID:
1R9O

# Drug_Target_10_Pathway:
Clopidogrel Pathway	SMP00260
Cyclophosphamide Pathway	SMP00447
Ifosfamide Pathway	SMP00448

# Drug_Target_10_Pfam_Domain_Function:
PF00067	p450

# Drug_Target_10_Protein_Sequence:
>Cytochrome P450 2C9
MDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV
YGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW
KEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS
IIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM
KSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE
TTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID
LLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK
KSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP
PFYQLCFIPV

# Drug_Target_10_Reaction:
Not Available

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S- warfarin, diclofenac, phenytoin, tolbutamide and losartan

# Drug_Target_10_SwissProt_ID:
P11712

# Drug_Target_10_SwissProt_Name:
CP2C9_HUMAN

# Drug_Target_10_Synonyms:
(R)-limonene 6-monooxygenase
(S)- limonene 7-monooxygenase
(S)-limonene 6-monooxygenase
CYPIIC9
EC 1.14.13.48
EC 1.14.13.49
EC 1.14.13.80
P-450MP
P450 MP-4/MP-8
P450 PB-1
S- mephenytoin 4-hydroxylase

# Drug_Target_10_Theoretical_pI:
7.99

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Periplasm

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
Not Available

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
AF186393

# Drug_Target_11_GenBank_ID_Protein:
Not Available

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
Ddes_2038

# Drug_Target_11_Gene_Sequence:
>981 bp
ATGAGGAACGGCACATCACTGCTTCTGCTGGCGGCTATAGCCCTGGCTGGCGCGGCGTGT
CTCACGGCGATGGGAGGCACGGCCAAGGCCGCAGCCCTGGAGCCAACAGACAGCGGCGCG
CCATCGGCTATAGTCATGTTTCCGGTCGGCGAAAAGCCCAATCCCAAGGGCGCGGCCATG
AAACCCGTGGTTTTCAACCATCTTATCCACGAAAAGAAGATTGACAACTGCGAGACCTGT
CACCACACGGGCGATCCGGTGTCCTGTAGCACCTGTCACACGGTAGAAGGCAAGGCCGAG
GGCAATTACATCACCCTTGACCGCGCCATGCATGCCACCAATATCGCCAAACGCGCCAAG
GGCAACACGCCCGTCAGCTGCGTGAGCTGTCACGAACAGCAAACCAAAGAGCGGCGCGAA
TGCGCGGGTTGTCACGCCATTGTCACGCCCAAGCGTGACGAGGCATGGTGCGCCACCTGC
CACAACATCACGCCTTCAATGACGCCCGAACAGATGCAGAAGGGCATTAACGGCACCCTG
CTGCCCGGCGATAACGAAGCTCTGGCGGCAGAAACCGTGCTGGCCCAGAAGACCGTTGAG
CCTGTTTCCCCCATGCTGGCCCCCTACAAGGTGGTCATTGATGCCCTGGCTGACAAGTAC
GAGCCGAGCAACTTTACCCACCGCCGCCACCTCACGTCCCTTATGGAAAGAATCAAGGAC
GACAAGCTGGCCCAGGCTTTCCACAACAAGCCTGAAATCCTGTGCGCTACCTGCCACCAC
AGAAGCCCGCTTTCCCTTACGCCTCCCAAGTGCGGCAGCTGCCACACCAAGGAGATCGAC
AAGGCCAATCCCGGTCGTCCCAACCTTATGGCCGCCTACCATCTGCAGTGCATGGGTTGC
CACAAGGGCATGGATGTCGCGCGTCCTCGTGACACCGACTGCACCACTTGCCATAAGGCT
GCGCCCAAGAGCGCCGACTAG

# Drug_Target_11_General_Function:
Involved in iron ion binding

# Drug_Target_11_General_References:
10368280	Matias PM, Coelho R, Pereira IA, Coelho AV, Thompson AW, Sieker LC, Gall JL, Carrondo MA: The primary and three-dimensional structures of a nine-haem cytochrome c from Desulfovibrio desulfuricans ATCC 27774 reveal a new member of the Hmc family. Structure. 1999 Feb 15;7(2):119-30.
10471375	Saraiva LM, da Costa PN, LeGall J: Sequencing the gene encoding desulfovibrio desulfuricans ATCC 27774 nine-heme cytochrome c. Biochem Biophys Res Commun. 1999 Sep 7;262(3):629-34.
10555582	Matias PM, Saraiva LM, Soares CM, Coelho AV, LeGall J, Carrondo MA: Nine-haem cytochrome c from Desulfovibrio desulfuricans ATCC 27774:primary sequence determination, crystallographic refinement at 1.8 and modelling studies of its interaction with the tetrahaem cytochrome c3. J Biol Inorg Chem. 1999 Aug;4(4):478-94.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
4902

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
35026

# Drug_Target_11_Name:
Nine-heme cytochrome c

# Drug_Target_11_Number_of_Residues:
326

# Drug_Target_11_PDB_ID:
1OFY

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_11_Protein_Sequence:
>Nine-heme cytochrome c
MRNGTSLLLLAAIALAGAACLTAMGGTAKAAALEPTDSGAPSAIVMFPVGEKPNPKGAAM
KPVVFNHLIHEKKIDNCETCHHTGDPVSCSTCHTVEGKAEGNYITLDRAMHATNIAKRAK
GNTPVSCVSCHEQQTKERRECAGCHAIVTPKRDEAWCATCHNITPSMTPEQMQKGINGTL
LPGDNEALAAETVLAQKTVEPVSPMLAPYKVVIDALADKYEPSNFTHRRHLTSLMERIKD
DKLAQAFHNKPEILCATCHHRSPLSLTPPKCGSCHTKEIDKANPGRPNLMAAYHLQCMGC
HKGMDVARPRDTDCTTCHKAAPKSAD

# Drug_Target_11_Reaction:
Not Available

# Drug_Target_11_Signals:
1-30

# Drug_Target_11_Specific_Function:
May form part of a transmembrane redox complex through which electrons are transferred to the cytoplasm for reduction of sulfate

# Drug_Target_11_SwissProt_ID:
Q9RN68

# Drug_Target_11_SwissProt_Name:
CYC9_DESDA

# Drug_Target_11_Synonyms:
9Hcc
Nine-heme cytochrome c precursor

# Drug_Target_11_Theoretical_pI:
7.97

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Periplasm

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
Not Available

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
Not Available

# Drug_Target_12_GenBank_ID_Protein:
Not Available

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
Not Available

# Drug_Target_12_Gene_Sequence:
Not Available

# Drug_Target_12_General_Function:
Involved in iron ion binding

# Drug_Target_12_General_References:
229424	Haser R, Pierrot M, Frey M, Payan F, Astier JP, Bruschi M, Le Gall J: Structure and sequence of the multihaem cytochrome c3. Nature. 1979 Dec 20-27;282(5741):806-10.
2539120	Loutfi M, Guerlesquin F, Bianco P, Haladjian J, Bruschi M: Comparative studies of polyhemic cytochromes c isolated from Desulfovibrio vulgaris (Hildenborough) and Desulfovibrio desulfuricans (Norway). Biochem Biophys Res Commun. 1989 Mar 15;159(2):670-6.
6292223	Pierrot M, Haser R, Frey M, Payan F, Astier JP: Crystal structure and electron transfer properties of cytochrome c3. J Biol Chem. 1982 Dec 10;257(23):14341-8.
7966289	Czjzek M, Payan F, Guerlesquin F, Bruschi M, Haser R: Crystal structure of cytochrome c3 from Desulfovibrio desulfuricans Norway at 1.7 A resolution. J Mol Biol. 1994 Nov 4;243(4):653-67.
8142476	Bruschi M, Leroy G, Guerlesquin F, Bonicel J: Amino-acid sequence of the cytochrome c3 (M(r) 26,000) from Desulfovibrio desulfuricans Norway and a comparison with those of the other polyhemic cytochromes from Desulfovibrio. Biochim Biophys Acta. 1994 Mar 16;1205(1):123-31.

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
5221

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
12622

# Drug_Target_12_Name:
Cytochrome c3, 13 kDa

# Drug_Target_12_Number_of_Residues:
118

# Drug_Target_12_PDB_ID:
2CY3

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_12_Protein_Sequence:
>Cytochrome c3, 13 kDa
ADAPGDDYVISAPEGMKAKPKGDKPGALQKTVPFPHTKHATVECVQCHHTLEADGGAVKK
CTTSGCHDSLEFRDKANAKDIKLVENAFHTQCIDCHKALKKDKKPTGPTACGKCHTTN

# Drug_Target_12_Reaction:
Not Available

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
Participates in sulfate respiration coupled with phosphorylation by transferring electrons from the enzyme dehydrogenase to ferredoxin

# Drug_Target_12_SwissProt_ID:
P00136

# Drug_Target_12_SwissProt_Name:
CYC31_DESNO

# Drug_Target_12_Synonyms:
Not Available

# Drug_Target_12_Theoretical_pI:
8.23

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Periplasm

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
Not Available

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
U23766

# Drug_Target_13_GenBank_ID_Protein:
Not Available

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
ccpA

# Drug_Target_13_Gene_Sequence:
>1041 bp
ATGCAGTCCTCGCAACTGCTCCCGCTTGGCAGCCTGTTGCTGTCGTTCGCCACGCCCCTC
GCCCAGGCCGATGCCCTGCACGACCAGGCCAGCGCGCTGTTCAAACCCATCCCCGAGCAG
GTCACCGAGCTACGCGGCCAGCCCATCAGCGAGCAACAGCGCGAACTCGGCAAGAAACTG
TTCTTCGACCCGCGCCTGTCACGCAGCCATGTGCTCAGCTGCAACACCTGCCACAACGTC
GGCACCGGCGGCGCCGACAACGTACCGACGTCGGTCGGTCACGGCTGGCAGAAGGGGCCA
CGCAATTCACCGACGGTCTTCAACGCCGTGTTCAATGCCGCGCAGTTCTGGGATGGCCGT
GCCAAGGACCTGGGGGAGCAGGCCAAGGGTCCGATCCAGAACAGCGTCGAGATGCACAGT
ACCCCGCAGTTGGTCGAACAGACCCTGGGCAGCATCCCGGAATACGTGGACGCCTTCCGC
AAGGCCTTCCCCAAGGCCGGCAAGCCGGTCAGCTTCGACAACATGGCGCTGGCCATCGAG
GCCTACGAGGCGACCCTGGTGACTCCGGACTCGCCCTTCGACCTGTATCTCAAGGGCGAC
GACAAGGCCCTCGACGCACAGCAGAAGAAAGGCCTCAAGGCATTCATGGACAGTGGCTGC
AGCGCCTGCCACAACGGCATCAACCTGGGCGGCCAGGCCTACTTCCCGTTCGGCCTGGTG
AAGAAGCCCGACGCCAGCGTGCTGCCCAGCGGCGACAAGGGCCGCTTCGCCGTGACCAAG
ACCCAGAGCGACGAGTACGTATTCCGCGCCGCGCCCCTGCGCAACGTCGCCCTCACCGCG
CCGTACTTCCACAGCGGCCAGGTCTGGGAACTCAAGGACGCGGTGGCGATCATGGGCAAC
GCCCAGCTCGGCAAGCAGTTGGCGCCGGACGACGTGGAGAACATCGTCGCCTTCCTGCAC
AGCCTGAGCGGCAAGCAGCCGCGCGTCGAATATCCGCTGCTGCCGGCCAGCACGGAGACC
ACGCCGCGTCCCGCGGAATAA

# Drug_Target_13_General_Function:
Involved in iron ion binding

# Drug_Target_13_General_References:
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
1657179	Ellfolk N, Ronnberg M, Osterlund K: Structural and functional features of Pseudomonas cytochrome c peroxidase. Biochim Biophys Acta. 1991 Oct 11;1080(1):68-77.
2546794	Ronnberg M, Kalkkinen N, Ellfolk N: The primary structure of Pseudomonas cytochrome c peroxidase. FEBS Lett. 1989 Jul 3;250(2):175-8.
3030432	Ronnberg M: Amino acid sequences of the two heme c-binding sites of Pseudomonas cytochrome-c peroxidase. Biochim Biophys Acta. 1987 Mar 18;912(1):82-6.
7781769	Ridout CJ, James R, Greenwood C: Nucleotide sequence encoding the di-haem cytochrome c551 peroxidase from Pseudomonas aeruginosa. FEBS Lett. 1995 May 29;365(2-3):152-4.
8543038	Samyn B, Van Craenenbroeck K, De Smet L, Vandenberghe I, Pettigrew G, Van Beeumen J: A reinvestigation of the covalent structure of Pseudomonas aeruginosa cytochrome c peroxidase. FEBS Lett. 1995 Dec 18;377(2):145-9.
8591033	Fulop V, Ridout CJ, Greenwood C, Hajdu J: Crystal structure of the di-haem cytochrome c peroxidase from Pseudomonas aeruginosa. Structure. 1995 Nov 15;3(11):1225-33.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
5222

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
37404

# Drug_Target_13_Name:
Cytochrome c551 peroxidase

# Drug_Target_13_Number_of_Residues:
346

# Drug_Target_13_PDB_ID:
1EB7

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF03150	CCP_MauG

# Drug_Target_13_Protein_Sequence:
>Cytochrome c551 peroxidase
MQSSQLLPLGSLLLSFATPLAQADALHDQASALFKPIPEQVTELRGQPISEQQRELGKKL
FFDPRLSRSHVLSCNTCHNVGTGGADNVPTSVGHGWQKGPRNSPTVFNAVFNAAQFWDGR
AKDLGEQAKGPIQNSVEMHSTPQLVEQTLGSIPEYVDAFRKAFPKAGKPVSFDNMALAIE
AYEATLVTPDSPFDLYLKGDDKALDAQQKKGLKAFMDSGCSACHNGINLGGQAYFPFGLV
KKPDASVLPSGDKGRFAVTKTQSDEYVFRAAPLRNVALTAPYFHSGQVWELKDAVAIMGN
AQLGKQLAPDDVENIVAFLHSLSGKQPRVEYPLLPASTETTPRPAE

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
1-23

# Drug_Target_13_Specific_Function:
Catalyzes the peroxidative oxidation of azurin and cytochrome c551. Likely to provide protection against toxic peroxides

# Drug_Target_13_SwissProt_ID:
P14532

# Drug_Target_13_SwissProt_Name:
CCPR_PSEAE

# Drug_Target_13_Synonyms:
CCP
Cytochrome c peroxidase
Cytochrome c551 peroxidase precursor
EC 1.11.1.5

# Drug_Target_13_Theoretical_pI:
6.72

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_14_Cellular_Location:
Periplasm

# Drug_Target_14_Chromosome_Location:
Not Available

# Drug_Target_14_Drug_References:
Not Available

# Drug_Target_14_Essentiality:
Non-Essential

# Drug_Target_14_GenAtlas_ID:
Not Available

# Drug_Target_14_GenBank_ID_Gene:
D31702

# Drug_Target_14_GenBank_ID_Protein:
Not Available

# Drug_Target_14_GeneCard_ID:
Not Available

# Drug_Target_14_Gene_Name:
DvMF_2499

# Drug_Target_14_Gene_Sequence:
>393 bp
ATGAAAAAGATGTTCCTCACCGGTGTGCTCGCGCTGGCCGTTGCCATCGCCATGCCCGCC
CTTGCCGCCGCCCCGAAGGCCCCTGCCGACGGTCTGAAGATGGACAAGACCAAGCAGCCC
GTGGTCTTCAACCACTCGACCCACAAGGCCGTGAAGTGTGGCGACTGTCACCACCCGGTC
AACGGCAAGGAAGACTACCAGAAGTGCGCCACCGCCGGTTGCCACGACAACATGGACAAG
AAGGACAAGTCCGCCAAGGGCTACTACCACGCCATGCATGACAAGGGCACCAAGTTCAAG
AGCTGCGTGGGCTGCCACCTTGAAACCGCCGGCGCCGACGCCGCCAAGAAAAAGGAACTG
ACGGGCTGCAAGGGCTCCAAGTGCCATAGCTAG

# Drug_Target_14_General_Function:
Involved in iron ion binding

# Drug_Target_14_General_References:
1668723	Park JS, Kano K, Morimoto Y, Higuchi Y, Yasuoka N, Ogata M, Niki K, Akutsu H: 1H NMR studies on ferricytochrome c3 from Desulfovibrio vulgaris Miyazaki F and its interaction with ferredoxin I. J Biomol NMR. 1991 Sep;1(3):271-82.
6249799	Shinkai W, Hase T, Yagi T, Matsubara H: Amino acid sequence of cytochrome c3 from Desulfovibrio vulgaris, Miyazaki. J Biochem. 1980 Jun;87(6):1747-56.
6268619	Higuchi Y, Bando S, Kusunoki M, Matsuura Y, Yasuoka N, Kakudo M, Yamanaka T, Yagi T, Inokuchi H: The structure of cytochrome c3 from Desulfovibrio vulgaris Miyazaki at 2.5 A resolution. J Biochem. 1981 May;89(5):1659-62.

# Drug_Target_14_HGNC_ID:
Not Available

# Drug_Target_14_HPRD_ID:
Not Available

# Drug_Target_14_ID:
4923

# Drug_Target_14_Locus:
Not Available

# Drug_Target_14_Molecular_Weight:
13843

# Drug_Target_14_Name:
Cytochrome c3

# Drug_Target_14_Number_of_Residues:
130

# Drug_Target_14_PDB_ID:
1J0O

# Drug_Target_14_Pathway:
Not Available

# Drug_Target_14_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_14_Protein_Sequence:
>Cytochrome c3
MKKMFLTGVLALAVAIAMPALAAAPKAPADGLKMDKTKQPVVFNHSTHKAVKCGDCHHPV
NGKEDYQKCATAGCHDNMDKKDKSAKGYYHAMHDKGTKFKSCVGCHLETAGADAAKKKEL
TGCKGSKCHS

# Drug_Target_14_Reaction:
Not Available

# Drug_Target_14_Signals:
1-23

# Drug_Target_14_Specific_Function:
Participates in sulfate respiration coupled with phosphorylation by transferring electrons from the enzyme dehydrogenase to ferredoxin

# Drug_Target_14_SwissProt_ID:
P00132

# Drug_Target_14_SwissProt_Name:
CYC3_DESVM

# Drug_Target_14_Synonyms:
Cytochrome c3 precursor

# Drug_Target_14_Theoretical_pI:
9.54

# Drug_Target_14_Transmembrane_Regions:
None

# Drug_Target_15_Cellular_Location:
Not Available

# Drug_Target_15_Chromosome_Location:
Not Available

# Drug_Target_15_Drug_References:
Not Available

# Drug_Target_15_Essentiality:
Non-Essential

# Drug_Target_15_GenAtlas_ID:
Not Available

# Drug_Target_15_GenBank_ID_Gene:
CP000143

# Drug_Target_15_GenBank_ID_Protein:
Not Available

# Drug_Target_15_GeneCard_ID:
Not Available

# Drug_Target_15_Gene_Name:
cycP

# Drug_Target_15_Gene_Sequence:
>450 bp
ATGAGACGAGTTCTTCTAGCCACCCTGATGGCCGCCCTTCCCGCCGCAGCCATGGCTGCC
GATGCCGAACATGTGGTCGAGGCCCGCAAGGGCTATTTCTCCCTCGTGGCTCTCGAATTC
GGGCCGCTTGCCGCGATGGCCAAGGGCGAGATGCCCTATGATGCCGCGGCCGCCAAGGCG
CATGCGTCCGATCTCGTGACCCTGACCAAATACGATCCCTCCGACCTCTACGCCCCCGGC
ACCTCGGCGGACGATGTGAAGGGCACGGCCGCGAAGGCCGCGATCTGGCAGGATGCAGAT
GGCTTCCAGGCGAAGGGCATGGCCTTCTTCGAGGCGGTGGCGGCCCTCGAACCTGCGGCC
GGCGCGGGCCAGAAGGAGCTGGCCGCCGCCGTGGGCAAGGTCGGCGGCACCTGCAAATCC
TGCCACGACGACTTCCGGGTGAAGAGATAA

# Drug_Target_15_General_Function:
Involved in iron ion binding

# Drug_Target_15_General_References:
6273892	Ambler RP, Bartsch RG, Daniel M, Kamen MD, McLellan L, Meyer TE, Van Beeumen J: Amino acid sequences of bacterial cytochromes c' and c-556. Proc Natl Acad Sci U S A. 1981 Nov;78(11):6854-7.

# Drug_Target_15_HGNC_ID:
Not Available

# Drug_Target_15_HPRD_ID:
Not Available

# Drug_Target_15_ID:
5223

# Drug_Target_15_Locus:
Not Available

# Drug_Target_15_Molecular_Weight:
15363

# Drug_Target_15_Name:
Cytochrome c'

# Drug_Target_15_Number_of_Residues:
149

# Drug_Target_15_PDB_ID:
1GQA

# Drug_Target_15_Pathway:
Not Available

# Drug_Target_15_Pfam_Domain_Function:
PF01322	Cytochrom_C_2

# Drug_Target_15_Protein_Sequence:
>Cytochrome c'
MRRVLLATLMAALPAAAMAADAEHVVEARKGYFSLVALEFGPLAAMAKGEMPYDAAAAKA
HASDLVTLTKYDPSDLYAPGTSADDVKGTAAKAAIWQDADGFQAKGMAFFEAVAALEPAA
GAGQKELAAAVGKVGGTCKSCHDDFRVKR

# Drug_Target_15_Reaction:
Not Available

# Drug_Target_15_Signals:
1-19

# Drug_Target_15_Specific_Function:
Cytochrome c' is the most widely occurring bacterial c- type cytochrome. Cytochromes c' are high-spin proteins and the heme has no sixth ligand. Their exact function is not known

# Drug_Target_15_SwissProt_ID:
P00148

# Drug_Target_15_SwissProt_Name:
CYCP_RHOS4

# Drug_Target_15_Synonyms:
Cytochrome c' precursor

# Drug_Target_15_Theoretical_pI:
6.25

# Drug_Target_15_Transmembrane_Regions:
None

# Drug_Target_16_Cellular_Location:
Not Available

# Drug_Target_16_Chromosome_Location:
Not Available

# Drug_Target_16_Drug_References:
Not Available

# Drug_Target_16_Essentiality:
Non-Essential

# Drug_Target_16_GenAtlas_ID:
Not Available

# Drug_Target_16_GenBank_ID_Gene:
AF187324

# Drug_Target_16_GenBank_ID_Protein:
Not Available

# Drug_Target_16_GeneCard_ID:
Not Available

# Drug_Target_16_Gene_Name:
cytc3

# Drug_Target_16_Gene_Sequence:
>387 bp
GTGAAAAAAACTCTTGCTCTTACCTGTATGCTGGCCCTGCTTCTTGCCGTGAGCGCCTGG
GCCGCGCCTGCCGTGCCTGACAAGCCTGTCGAAGTCAAAGGCTCGCAAAAGACAGTCATG
TTCCCCCACGCTCCCCACGAAAAAGTGGAATGCGTGACCTGCCACCACCTGGTGGACGGC
AAGGAAAGCTATGCCAAATGCGGCAGCTCCGGCTGCCATGACGATCTGACCGCCAAAAAG
GGCGAAAAGAGCCTGTACTACGTCGTTCACGCCAAGGGCGAACTCAAGCATACGAGCTGC
CTTGCCTGTCACAGCAAGGTGGTGGCTGAAAAGCCCGAGCTCAAGAAAGACCTTACCGGT
TGCGCCAAGTCCAAGTGTCATCCGTAG

# Drug_Target_16_General_Function:
Involved in iron ion binding

# Drug_Target_16_General_References:
11551953	Louro RO, Bento I, Matias PM, Catarino T, Baptista AM, Soares CM, Carrondo MA, Turner DL, Xavier AV: Conformational component in the coupled transfer of multiple electrons and protons in a monomeric tetraheme cytochrome. J Biol Chem. 2001 Nov 23;276(47):44044-51. Epub 2001 Sep 10.

# Drug_Target_16_HGNC_ID:
Not Available

# Drug_Target_16_HPRD_ID:
Not Available

# Drug_Target_16_ID:
4968

# Drug_Target_16_Locus:
Not Available

# Drug_Target_16_Molecular_Weight:
13795

# Drug_Target_16_Name:
Cytochrome c3

# Drug_Target_16_Number_of_Residues:
128

# Drug_Target_16_PDB_ID:
1GMB

# Drug_Target_16_Pathway:
Not Available

# Drug_Target_16_Pfam_Domain_Function:
PF02085	Cytochrom_CIII

# Drug_Target_16_Protein_Sequence:
>Cytochrome c3
MKKTLALTCMLALLLAVSAWAAPAVPDKPVEVKGSQKTVMFPHAPHEKVECVTCHHLVDG
KESYAKCGSSGCHDDLTAKKGEKSLYYVVHAKGELKHTSCLACHSKVVAEKPELKKDLTG
CAKSKCHP

# Drug_Target_16_Reaction:
Not Available

# Drug_Target_16_Signals:
1-21

# Drug_Target_16_Specific_Function:
Not Available

# Drug_Target_16_SwissProt_ID:
Q9L915

# Drug_Target_16_SwissProt_Name:
Q9L915_DESDE

# Drug_Target_16_Synonyms:
Cytochrome c3 precursor

# Drug_Target_16_Theoretical_pI:
8.65

# Drug_Target_16_Transmembrane_Regions:
None

# Drug_Target_17_Cellular_Location:
Periplasm

# Drug_Target_17_Chromosome_Location:
Not Available

# Drug_Target_17_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_17_Essentiality:
Non-Essential

# Drug_Target_17_GenAtlas_ID:
Not Available

# Drug_Target_17_GenBank_ID_Gene:
X16452

# Drug_Target_17_GenBank_ID_Protein:
45358

# Drug_Target_17_GeneCard_ID:
Not Available

# Drug_Target_17_Gene_Name:
nirS

# Drug_Target_17_Gene_Sequence:
>1707 bp
ATGCCATTTGGCAAGCCACTGGTGGGCACCTTGCTCGCCTCGCTGACGCTGCTGGGCCTG
GCCACCGCTCACGCCAAGGACGACATGAAAGCCGCCGAGCAATACCAGGGTGCCGCTTCC
GCCGTCGATCCCGCTCACGTGGTGCGCACCAACGGCGCTCCCGACATGAGTGAAAGCGAG
TTCAACGAGGCCAAGCAGATCTACTTCCAACGCTGCGCCGGTTGCCACGGCGTCCTGCGC
AAGGGCGCCACCGGCAAGCCGCTGACCCCGGACATCACCCAGCAACGCGGCCAGCAATAC
CTGGAAGCGCTGATCACCTACGGCACCCCGCTGGGCATGCCGAACTGGGGCAGCTCCGGC
GAGCTGAGCAAGGAACAGATCACCCTGATGGCCAAGTACATCCAGCACACCCCGCCGCAA
CCGCCGGAGTGGGGCATGCCGGAGATGCGCGAATCGTGGAAGGTGCTGGTGAAGCCGGAG
GACCGGCCGAAGAAACAGCTCAACGACCTCGACCTGCCCAACCTGTTCTCGGTGACCCTG
CGCGACGCCGGGCAGATCGCCCTGGTCGACGGCGACAGCAAAAAGATCGTCAAGGTCATC
GATACCGGCTATGCCGTGCATATCTCGCGGATGTCCGCTTCCGGCCGCTACCTGCTGGTG
ATCGGCCGCGACGCGCGGATCGACATGATCGACCTGTGGGCCAAGGAGCCGACCAAGGTC
GCCGAGATCAAGATCGGCATCGAGGCGCGCTCGGTGGAAAGCTCCAAGTTCAAGGGCTAC
GAGGACCGCTACACCATCGCCGGCGCCTACTGGCCGCCGCAGTTCGCGATCATGGACGGC
GAGACCCTGGAACCGAAGCAGATCGTCTCCACCCGCGGCATGACCGTAGACACCCAGACC
TACCACCCGGAACCGCGCGTGGCGGCGATCATCGCCTCCCACGAGCACCCCGAGTTCATC
GTCAACGTGAAGGAGACCGGCAAGGTCCTGCTGGTCAACTACAAGGATATCGACAACCTC
ACCGTCACCAGCATCGGTGCGGCGCCGTTCCTCCACGACGGCGGCTGGGACAGCAGCCAC
CGCTACTTCATGACCGCCGCCAACAACTCCAACAAGGTTGCCGTGATCGACTCCAAGGAC
CGTCGCCTGTCGGCCCTGGTCGACGTCGGCAAGACCCCGCACCCGGGGCGTGGCGCCAAC
TTCGTGCATCCCAAGTACGGCCCGGTGTGGAGCACCAGCCACCTGGGCGACGGCAGCATC
TCGCTGATCGGCACCGATCCGAAGAACCATCCGCAGTACGCCTGGAAGAAAGTCGCCGAA
CTACAGGGCCAGGGCGGCGGCTCGCTGTTCATCAAGACCCATCCGAAGTCCTCGCACCTC
TACGTCGACACCACCTTCAACCCCGACGCCAGGATCAGCCAGAGCGTCGCGGTGTTCGAC
CTGAAGAACCTCGACGCCAAGTACCAGGTGCTGCCGATCGCCGAATGGGCCGATCTCGGC
GAAGGCGCCAAGCGGGTGGTGCAGCCCGAGTACAACAAGCGCGGCGATGAAGTCTGGTTC
TCGGTGTGGAACGGCAAGAACGACAGCTCCGCGCTGGTGGTGGTGGACGACAAGACCCTG
AAGCTCAAGGCCGTGGTCAAGGACCCGCGGCTGATCACCCCGACCGGTAAGTTCAACGTC
TACAACACCCAGCACGACGTGTACTGA

# Drug_Target_17_General_Function:
Energy production and conversion

# Drug_Target_17_General_References:
10329702	Nurizzo D, Cutruzzola F, Arese M, Bourgeois D, Brunori M, Cambillau C, Tegoni M: Does the reduction of c heme trigger the conformational change of crystalline nitrite reductase? J Biol Chem. 1999 May 21;274(21):14997-5004.
10984043	Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, Garber RL, Goltry L, Tolentino E, Westbrock-Wadman S, Yuan Y, Brody LL, Coulter SN, Folger KR, Kas A, Larbig K, Lim R, Smith K, Spencer D, Wong GK, Wu Z, Paulsen IT, Reizer J, Saier MH, Hancock RE, Lory S, Olson MV: Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature. 2000 Aug 31;406(6799):959-64.
11226222	Cutruzzola F, Brown K, Wilson EK, Bellelli A, Arese M, Tegoni M, Cambillau C, Brunori M: The nitrite reductase from Pseudomonas aeruginosa: essential role of two active-site histidines in the catalytic and structural properties. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2232-7.
11563915	Brown K, Roig-Zamboni V, Cutruzzola' F, Arese M, Sun W, Brunori M, Cambillau C, Tegoni M: Domain swing upon His to Ala mutation in nitrite reductase of Pseudomonas aeruginosa. J Mol Biol. 2001 Sep 21;312(3):541-54.
2152881	Nordling M, Young S, Karlsson BG, Lundberg LG: The structural gene for cytochrome c551 from Pseudomonas aeruginosa. The nucleotide sequence shows a location downstream of the nitrite reductase gene. FEBS Lett. 1990 Jan 1;259(2):230-2.
2155133	Arai H, Sanbongi Y, Igarashi Y, Kodama T: Cloning and sequencing of the gene encoding cytochrome c-551 from Pseudomonas aeruginosa. FEBS Lett. 1990 Feb 12;261(1):196-8.
2506077	Silvestrini MC, Galeotti CL, Gervais M, Schinina E, Barra D, Bossa F, Brunori M: Nitrite reductase from Pseudomonas aeruginosa: sequence of the gene and the protein. FEBS Lett. 1989 Aug 28;254(1-2):33-8.
9331415	Nurizzo D, Silvestrini MC, Mathieu M, Cutruzzola F, Bourgeois D, Fulop V, Hajdu J, Brunori M, Tegoni M, Cambillau C: N-terminal arm exchange is observed in the 2.15 A crystal structure of oxidized nitrite reductase from Pseudomonas aeruginosa. Structure. 1997 Sep 15;5(9):1157-71.
9760233	Nurizzo D, Cutruzzola F, Arese M, Bourgeois D, Brunori M, Cambillau C, Tegoni M: Conformational changes occurring upon reduction and NO binding in nitrite reductase from Pseudomonas aeruginosa. Biochemistry. 1998 Oct 6;37(40):13987-96.

# Drug_Target_17_HGNC_ID:
Not Available

# Drug_Target_17_HPRD_ID:
Not Available

# Drug_Target_17_ID:
3127

# Drug_Target_17_Locus:
Not Available

# Drug_Target_17_Molecular_Weight:
62654

# Drug_Target_17_Name:
Nitrite reductase

# Drug_Target_17_Number_of_Residues:
568

# Drug_Target_17_PDB_ID:
1GJQ

# Drug_Target_17_Pathway:
Not Available

# Drug_Target_17_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02239	Cytochrom_D1

# Drug_Target_17_Protein_Sequence:
>Nitrite reductase precursor
MPFGKPLVGTLLASLTLLGLATAHAKDDMKAAEQYQGAASAVDPAHVVRTNGAPDMSESE
FNEAKQIYFQRCAGCHGVLRKGATGKPLTPDITQQRGQQYLEALITYGTPLGMPNWGSSG
ELSKEQITLMAKYIQHTPPQPPEWGMPEMRESWKVLVKPEDRPKKQLNDLDLPNLFSVTL
RDAGQIALVDGDSKKIVKVIDTGYAVHISRMSASGRYLLVIGRDARIDMIDLWAKEPTKV
AEIKIGIEARSVESSKFKGYEDRYTIAGAYWPPQFAIMDGETLEPKQIVSTRGMTVDTQT
YHPEPRVAAIIASHEHPEFIVNVKETGKVLLVNYKDIDNLTVTSIGAAPFLHDGGWDSSH
RYFMTAANNSNKVAVIDSKDRRLSALVDVGKTPHPGRGANFVHPKYGPVWSTSHLGDGSI
SLIGTDPKNHPQYAWKKVAELQGQGGGSLFIKTHPKSSHLYVDTTFNPDARISQSVAVFD
LKNLDAKYQVLPIAEWADLGEGAKRVVQPEYNKRGDEVWFSVWNGKNDSSALVVVDDKTL
KLKAVVKDPRLITPTGKFNVYNTQHDVY

# Drug_Target_17_Reaction:
nitric oxide + H2O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H+

# Drug_Target_17_Signals:
1-25

# Drug_Target_17_Specific_Function:
Nitric oxide + H(2)O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H(+)

# Drug_Target_17_SwissProt_ID:
P24474

# Drug_Target_17_SwissProt_Name:
NIRS_PSEAE

# Drug_Target_17_Synonyms:
Cytochrome cd1
Cytochrome oxidase
EC 1.7.2.1
EC 1.7.99.1
Hydroxylamine reductase
Nitrite reductase precursor

# Drug_Target_17_Theoretical_pI:
8.21

# Drug_Target_17_Transmembrane_Regions:
None

# Drug_Target_18_Cellular_Location:
Periplasm

# Drug_Target_18_Chromosome_Location:
Not Available

# Drug_Target_18_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_18_Essentiality:
Non-Essential

# Drug_Target_18_GenAtlas_ID:
Not Available

# Drug_Target_18_GenBank_ID_Gene:
M63807

# Drug_Target_18_GenBank_ID_Protein:
145081

# Drug_Target_18_GeneCard_ID:
Not Available

# Drug_Target_18_Gene_Name:
hmcA

# Drug_Target_18_Gene_Sequence:
>1638 bp
ATGAGGAACGGAAGGACACTGCTGCGATGGGCGGGAGTGTTGGCTGCCACCGCCATCATC
GGCGTCGGCGGTTTCTGGTCACAGGGGACGACCAAGGCCCTCCCCGAAGGGCCCGGCGAA
AAACGCGCCGACCTGATCGAGATCGGGGCCATGGAACGCTTCGGGAAGCTTGATCTTCCC
AAGGTGGCGTTCCGCCACGACCAGCACACCACCGCCGTGACGGGCATGGGCAAGGACTGC
GCCGCCTGTCACAAGAGCAAGGACGGCAAGATGTCGCTGAAGTTCATGCGGCTTGACGAC
AACAGCGCCGCTGAACTCAAGGAAATCTACCACGCCAACTGTATCGGCTGTCATACCGAC
CTCGCCAAGGCCGGTAAGAAGACCGGCCCGCAGGACGGCGAATGCCGCTCGTGCCACAAC
CCGAAGCCCTCTGCCGCCTCGTCGTGGAAGGAGATAGGCTTCGACAAGTCGCTGCACTAC
CGTCACGTGGCGTCCAAGGCCATCAAGCCCGTGGGCGACCCGCAGAAGAACTGCGGCGCT
TGCCACCACGTCTATGACGAAGCTTCCAAGAAGCTCGTATGGGGTAAGAACAAGGAAGAC
TCGTGCCGCGCCTGTCACGGCGAGAAGCCCGTGGACAAGCGTCCCGCGCTCGACACCGCC
GCCCACACCGCGTGCATCAGCTGCCACATGGACGTCGCCAAGACCAAGGCCGAGACCGGC
CCGGTCAACTGCGCCGGCTGCCACGCCCCCGAGGCGCAGGCCAAGTTCAAGGTGGTACGC
GAAGTGCCCCGCCTCGACCGCGGTCAGCCCGACGCCGCCCTCATCCTGCCCGTACCCGGC
AAGGATGCCCCGCGCGAGATGAAGGGCACCATGAAGCCGGTCGCCTTCGACCACAAGGCC
CACGAAGCCAAGGCCAACGACTGCCGCACCTGCCACCATGTGCGCATCGACACCTGCACC
GCCTGCCATACCGTGAACGGTACCGCAGACAGCAAGTTCGTCCAGCTTGAAAAGGCCATG
CACCAGCCCGACTCCATGCGCAGCTGCGTGGGTTGTCACAACACCCGCGTCCAGCAGCCC
ACCTGTGCCGGTTGCCACGGCTTCATCAAGCCCACGAAGAGCGATGCCCAGTGCGGCGTG
TGCCACGTGGCCGCCCCCGGCTTCGACGCCAAGCAGGTCGAAGCGGGCGCATTGCTGAAC
CTCAAGGCAGAGCAGCGTTCGCAGGTTGCCGCCTCCATGCTGTCGGCCCGTCCGCAGCCC
AAGGGCACCTTCGACCTCAATGACATCCCCGAAAAGGTCGTCATCGGCTCCATCGCCAAG
GAATACCAGCCCAGCGAGTTCCCGCACCGCAAGATCGTGAAGACGCTCATCGCCGGTATC
GGTGAAGACAAGCTGGCCGCCACCTTCCACATCGAGAAGGGCACGCTGTGCCAGGGCTGC
CACCACAACAGCCCCGCCAGCCTCACCCCGCCCAAATGCGCGAGCTGCCACGGCAAGCCC
TTCGACGCCGACAGGGGCGACCGTCCCGGTCTCAAGGCCGCCTACCACCAGCAGTGCATG
GGCTGCCACGACCGGATGAAGATCGAAAAGCCGGCGAACACCGCCTGCGTCGATTGCCAC
AAGGAACGCGCGAAATAG

# Drug_Target_18_General_Function:
Involved in iron ion binding

# Drug_Target_18_General_References:
12356749	Matias PM, Coelho AV, Valente FM, Placido D, LeGall J, Xavier AV, Pereira IA, Carrondo MA: Sulfate respiration in Desulfovibrio vulgaris Hildenborough. Structure of the 16-heme cytochrome c HmcA AT 2.5-A resolution and a view of its role in transmembrane electron transfer. J Biol Chem. 2002 Dec 6;277(49):47907-16. Epub 2002 Sep 27.
1313289	Bruschi M, Bertrand P, More C, Leroy G, Bonicel J, Haladjian J, Chottard G, Pollock WB, Voordouw G: Biochemical and spectroscopic characterization of the high molecular weight cytochrome c from Desulfovibrio vulgaris Hildenborough expressed in Desulfovibrio desulfuricans G200. Biochemistry. 1992 Mar 31;31(12):3281-8.
1846136	Pollock WB, Loutfi M, Bruschi M, Rapp-Giles BJ, Wall JD, Voordouw G: Cloning, sequencing, and expression of the gene encoding the high-molecular-weight cytochrome c from Desulfovibrio vulgaris Hildenborough. J Bacteriol. 1991 Jan;173(1):220-8.
2163671	Tan JA, Cowan JA: Coordination and redox properties of a novel triheme cytochrome from Desulfovibrio vulgaris (Hildenborough). Biochemistry. 1990 May 22;29(20):4886-92.
7925451	Verhagen MF, Pierik AJ, Wolbert RB, Mallee LF, Voorhorst WG, Hagen WR: Axial coordination and reduction potentials of the sixteen hemes in high-molecular-mass cytochrome c from Desulfovibrio vulgaris (Hildenborough). Eur J Biochem. 1994 Oct 1;225(1):311-9.
8335628	Rossi M, Pollock WB, Reij MW, Keon RG, Fu R, Voordouw G: The hmc operon of Desulfovibrio vulgaris subsp. vulgaris Hildenborough encodes a potential transmembrane redox protein complex. J Bacteriol. 1993 Aug;175(15):4699-711.

# Drug_Target_18_HGNC_ID:
Not Available

# Drug_Target_18_HPRD_ID:
Not Available

# Drug_Target_18_ID:
3189

# Drug_Target_18_Locus:
Not Available

# Drug_Target_18_Molecular_Weight:
58902

# Drug_Target_18_Name:
High-molecular-weight cytochrome c

# Drug_Target_18_Number_of_Residues:
545

# Drug_Target_18_PDB_ID:
1GWS

# Drug_Target_18_Pathway:
Not Available

# Drug_Target_18_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02085	Cytochrom_CIII

# Drug_Target_18_Protein_Sequence:
>High-molecular-weight cytochrome c precursor
MRNGRTLLRWAGVLAATAIIGVGGFWSQGTTKALPEGPGEKRADLIEIGAMERFGKLDLP
KVAFRHDQHTTAVTGMGKDCAACHKSKDGKMSLKFMRLDDNSAAELKEIYHANCIGCHTD
LAKAGKKTGPQDGECRSCHNPKPSAASSWKEIGFDKSLHYRHVASKAIKPVGDPQKNCGA
CHHVYDEASKKLVWGKNKEDSCRACHGEKPVDKRPALDTAAHTACISCHMDVAKTKAETG
PVNCAGCHAPEAQAKFKVVREVPRLDRGQPDAALILPVPGKDAPREMKGTMKPVAFDHKA
HEAKANDCRTCHHVRIDTCTACHTVNGTADSKFVQLEKAMHQPDSMRSCVGCHNTRVQQP
TCAGCHGFIKPTKSDAQCGVCHVAAPGFDAKQVEAGALLNLKAEQRSQVAASMLSARPQP
KGTFDLNDIPEKVVIGSIAKEYQPSEFPHRKIVKTLIAGIGEDKLAATFHIEKGTLCQGC
HHNSPASLTPPKCASCHGKPFDADRGDRPGLKAAYHQQCMGCHDRMKIEKPANTACVDCH
KERAK

# Drug_Target_18_Reaction:
Not Available

# Drug_Target_18_Signals:
1-31

# Drug_Target_18_Specific_Function:
HMWC (high-molecular-weight cytochrome c), ORF2, ORF3, ORF4, ORF5 and ORF6 in the HMC operon form a transmembrane protein complex that allows electron flow from the periplasmic hydrogenase to the cytoplasmic enzymes that catalyze reduction of sulfates

# Drug_Target_18_SwissProt_ID:
P24092

# Drug_Target_18_SwissProt_Name:
HMWC_DESVH

# Drug_Target_18_Synonyms:
Cytochrome CC3
High-molecular-weight cytochrome c precursor

# Drug_Target_18_Theoretical_pI:
8.67

# Drug_Target_18_Transmembrane_Regions:
None

# Drug_Target_19_Cellular_Location:
Not Available

# Drug_Target_19_Chromosome_Location:
Not Available

# Drug_Target_19_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_19_Essentiality:
Non-Essential

# Drug_Target_19_GenAtlas_ID:
Not Available

# Drug_Target_19_GenBank_ID_Gene:
AF119838

# Drug_Target_19_GenBank_ID_Protein:
6478241

# Drug_Target_19_GeneCard_ID:
Not Available

# Drug_Target_19_Gene_Name:
cycA

# Drug_Target_19_Gene_Sequence:
>435 bp
ATGAAAATCAAAACAATCATTGCCGTATTCGGGGTCTTATTTTCTGCTCATGCATTGGCT
GACGTGACTAACGCTGAAAAGTTGGTGTACAAATATACCAATATCGCTCACTCCGCCAAT
CCAATGTATGAAGCGCCTTCAATTACTGATGGCAAAATTTTCTTCAACCGCAAATTCAAA
ACACCAAGCGGCAAAGAAGCGGCGTGTGCATCTTGTCACACCAATAACCCGGCTAATGTA
GGTAAAAACATTGTTACCGGCAAAGAAATCCCACCACTGGCACCACGCGTCAATACCAAA
CGCTTCACAGATATCGACAAAGTAGAAGACGAATTCACCAAACACTGTAATGATATTCTG
GGTGCAGATTGCTCACCTTCAGAAAAAGCTAACTTCATTGCTTATTTGTTGACAGAAACC
AAGCCTACCAAATAA

# Drug_Target_19_General_Function:
Involved in iron ion binding

# Drug_Target_19_General_References:
10354493	Klarskov K, Leys D, Backers K, Costa HS, Santos H, Guisez Y, Van Beeumen JJ: Cytochrome c" from the obligate methylotroph Methylophilus methylotrophus, an unexpected homolog of sphaeroides heme protein from the phototroph Rhodobacter sphaeroides. Biochim Biophys Acta. 1999 May 26;1412(1):47-55.
10524262	Price NJ, Vijgenboom E, Ribeiro G, Costa JV, Canters GW, Santos H: Cloning and sequence analysis of the gene encoding Methylophilus methylotrophus cytochrome c", a unique protein with a perpendicular orientation of the histidinyl ligands. Biochim Biophys Acta. 1999 Sep 1;1413(1):55-61.
11327772	Brennan L, Turner DL, Fareleira P, Santos H: Solution structure of Methylophilus methylotrophus cytochrome c": insights into the structural basis of haem-ligand detachment. J Mol Biol. 2001 Apr 27;308(2):353-65.
12595732	Enguita FJ, Rodrigues L, Archer M, Sieker L, Rodrigues A, Pohl E, Turner DL, Santos H, Carrondo MA: Crystallization and preliminary X-ray characterization of cytochrome c" from the obligate methylotroph Methylophilus methylotrophus. Acta Crystallogr D Biol Crystallogr. 2003 Mar;59(Pt 3):580-3. Epub 2003 Feb 21.
1325909	Costa HS, Santos H, Turner DL, Xavier AV: Involvement of a labile axial histidine in coupling electron and proton transfer in Methylophilus methylotrophus cytochrome c''. Eur J Biochem. 1992 Sep 1;208(2):427-33.
2169241	Berry MJ, George SJ, Thomson AJ, Santos H, Turner DL: Cytochrome c'' isolated from Methylophilus methylotrophus. An example of bis-histidine-co-ordinated Fe3+ haem, with near-perpendicular orientation of the ligands. Biochem J. 1990 Sep 1;270(2):413-7.
8394812	Costa HS, Santos H, Turner DL: Characterization of the haem environment in Methylophilus methylotrophus ferricytochrome c" by 1H-NMR. Eur J Biochem. 1993 Aug 1;215(3):817-24.

# Drug_Target_19_HGNC_ID:
Not Available

# Drug_Target_19_HPRD_ID:
Not Available

# Drug_Target_19_ID:
3152

# Drug_Target_19_Locus:
Not Available

# Drug_Target_19_Molecular_Weight:
15792

# Drug_Target_19_Name:
Cytochrome c''

# Drug_Target_19_Number_of_Residues:
144

# Drug_Target_19_PDB_ID:
1OAE

# Drug_Target_19_Pathway:
Not Available

# Drug_Target_19_Pfam_Domain_Function:
PF09086	DUF1924

# Drug_Target_19_Protein_Sequence:
>Cytochrome c'' precursor
MKIKTIIAVFGVLFSAHALADVTNAEKLVYKYTNIAHSANPMYEAPSITDGKIFFNRKFK
TPSGKEAACASCHTNNPANVGKNIVTGKEIPPLAPRVNTKRFTDIDKVEDEFTKHCNDIL
GADCSPSEKANFIAYLLTETKPTK

# Drug_Target_19_Reaction:
Not Available

# Drug_Target_19_Signals:
1-20

# Drug_Target_19_Specific_Function:
Not Available

# Drug_Target_19_SwissProt_ID:
Q9RQB9

# Drug_Target_19_SwissProt_Name:
CYCA_METME

# Drug_Target_19_Synonyms:
Cytochrome c'' precursor

# Drug_Target_19_Theoretical_pI:
8.91

# Drug_Target_19_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X72298

# Drug_Target_1_GenBank_ID_Protein:
853826

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nrfA

# Drug_Target_1_Gene_Sequence:
>1437 bp
ATGACAAGGATAAAAATAAACGCACGCCGTATCTTCAGCTTATTGATTCCTTTTTTCTTT
TTCACTTCTGTTCACGCTGAACAAACGGCTGCTCCCGCAAAACCTGTAACTGTGGAAGCG
AAGAATGAAACCTTTGCCCCGCAGCATCCCGATCAATATCTCTCCTGGAAAGCCACCTCG
GAACAGTCAGAGCGTGTTGACGCCCTGGCGGAAGATCCACGGCTGGTGATCCTGTGGGCG
GGGTATCCCTTCTCGCGCGATTACAACAAGCCGCGTGGACATGCTTTTGCTGTGACCGAT
GTGCGTGAAACCCTGCGTACCGGTGCGCCGAAAAACGCTGAAGATGGTCCGCTACCGATG
GCATGCTGGAGTTGTAAAAGCCCGGATGTGGCGCGTCTGATCCAGAAAGACGGCGAAGAT
GGCTACTTCCACGGTAAATGGGCGCGCGGCGGTCCGGAAATCGTCAACAACTTAGGTTGT
GCCGATTGCCATAACACCGCCTCTCCAGAGTTCGCCAAAGGCAAACCGGAGTTAACCCTT
TCCCGTCCGTATGCGGCTCGCGCGATGGAAGCCATTGGTAAACCTTTTGAGAAAGCCGGA
CGTTTCGACCAGCAATCGATGGTTTGCGGTCAGTGCCATGTGGAGTATTACTTCGACGGC
AAAAACAAAGCGGTTAAATTCCCGTGGGATGACGGCATGAAAGTCGAAAATATGGAGCAG
TATTACGACAAAATTGCCTTCTCTGACTGGACTAACTCCCTGTCGAAAACGCCAATGCTG
AAAGCGCAGCACCCGGAATATGAAACCTGGACAGCGGGCATTCACGGTAAAAACAACGTG
ACCTGTATCGACTGCCATATGCCAAAAGTGCAGAACGCCGAAGGCAAACTCTACACCGAC
CATAAAATTGGTAATCCGTTTGATAACTTCGCCCAGACTTGTGCGAACTGCCATACCCAG
GACAAAGCTGCCTTGCAAAAAGTGGTCGCGGAACGTAAGCAGTCGATTAACGACCTGAAA
ATCAAGGTTGAAGATCAACTGGTTCACGCTCACTTCGAAGCGAAAGCAGCGCTGGATGCA
GGCGCGACGGAAGCTGAAATGAAGCCAATTCAGGACGATATCCGTCATGCCCAGTGGCGC
TGGGATCTGGCGATCGCTTCCCACGGCATTCATATGCACGCACCGGAAGAAGGTTTACGG
ATGCTCGGTACGGCGATGGATAAAGCGGCGGATGCACGCACCAAACTGGCGCGCCTGCTG
GCGACCAAAGGCATCACCCATGAAATCCAGATCCCGGATATCTCAACCAAAGAGAAAGCC
CAGCAGGCCATTGGCCTGAACATGGAACAAATCAAGGCCGAGAAGCAGGACTTCATCAAA
ACGGTGATCCCGCAGTGGGAAGAACAGGCACGTAAAAACGGTCTGTTAAGCCAATAA

# Drug_Target_1_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_1_General_References:
11863430	Bamford VA, Angove HC, Seward HE, Thomson AJ, Cole JA, Butt JN, Hemmings AM, Richardson DJ: Structure and spectroscopy of the periplasmic cytochrome c nitrite reductase from Escherichia coli. Biochemistry. 2002 Mar 5;41(9):2921-31.
7934939	Darwin A, Hussain H, Griffiths L, Grove J, Sambongi Y, Busby S, Cole J: Regulation and sequence of the structural gene for cytochrome c552 from Escherichia coli: not a hexahaem but a 50 kDa tetrahaem nitrite reductase. Mol Microbiol. 1993 Sep;9(6):1255-65.
8039676	Iobbi-Nivol C, Crooke H, Griffiths L, Grove J, Hussain H, Pommier J, Mejean V, Cole JA: A reassessment of the range of c-type cytochromes synthesized by Escherichia coli K-12. FEMS Microbiol Lett. 1994 Jun 1;119(1-2):89-94.
8265357	Blattner FR, Burland V, Plunkett G 3rd, Sofia HJ, Daniels DL: Analysis of the Escherichia coli genome. IV. DNA sequence of the region from 89.2 to 92.8 minutes. Nucleic Acids Res. 1993 Nov 25;21(23):5408-17.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9593308	Eaves DJ, Grove J, Staudenmann W, James P, Poole RK, White SA, Griffiths I, Cole JA: Involvement of products of the nrfEFG genes in the covalent attachment of haem c to a novel cysteine-lysine motif in the cytochrome c552 nitrite reductase from Escherichia coli. Mol Microbiol. 1998 Apr;28(1):205-16.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3700

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
53703

# Drug_Target_1_Name:
Cytochrome c-552 precursor

# Drug_Target_1_Number_of_Residues:
478

# Drug_Target_1_PDB_ID:
1GU6

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02335	Cytochrom_C552

# Drug_Target_1_Protein_Sequence:
>Cytochrome c-552 precursor
MTRIKINARRIFSLLIPFFFFTSVHAEQTAAPAKPVTVEAKNETFAPQHPDQYLSWKATS
EQSERVDALAEDPRLVILWAGYPFSRDYNKPRGHAFAVTDVRETLRTGAPKNAEDGPLPM
ACWSCKSPDVARLIQKDGEDGYFHGKWARGGPEIVNNLGCADCHNTASPEFAKGKPELTL
SRPYAARAMEAIGKPFEKAGRFDQQSMVCGQCHVEYYFDGKNKAVKFPWDDGMKVENMEQ
YYDKIAFSDWTNSLSKTPMLKAQHPEYETWTAGIHGKNNVTCIDCHMPKVQNAEGKLYTD
HKIGNPFDNFAQTCANCHTQDKAALQKVVAERKQSINDLKIKVEDQLVHAHFEAKAALDA
GATEAEMKPIQDDIRHAQWRWDLAIASHGIHMHAPEEGLRMLGTAMDKAADARTKLARLL
ATKGITHEIQIPDISTKEKAQQAIGLNMEQIKAEKQDFIKTVIPQWEEQARKNGLLSQ

# Drug_Target_1_Reaction:
ammonia + 2 H2O + 6 ferricytochrome c = nitrite + 6 ferrocytochrome c + 7 H+

# Drug_Target_1_Signals:
1-26

# Drug_Target_1_Specific_Function:
Plays a role in nitrite reduction

# Drug_Target_1_SwissProt_ID:
P0ABK9

# Drug_Target_1_SwissProt_Name:
NRFA_ECOLI

# Drug_Target_1_Synonyms:
Ammonia-forming cytochrome c nitrite reductase
Cytochrome c nitrite reductase
EC 1.7.2.2

# Drug_Target_1_Theoretical_pI:
7.27

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_20_Cellular_Location:
Periplasm (Potential)

# Drug_Target_20_Chromosome_Location:
Not Available

# Drug_Target_20_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_20_Essentiality:
Non-Essential

# Drug_Target_20_GenAtlas_ID:
Not Available

# Drug_Target_20_GenBank_ID_Gene:
X81880

# Drug_Target_20_GenBank_ID_Protein:
663196

# Drug_Target_20_GeneCard_ID:
Not Available

# Drug_Target_20_Gene_Name:
qheDH

# Drug_Target_20_Gene_Sequence:
>2127 bp
ATGGAACGGCTGATCGACAACTCTCATGGATGGCCGGGCCGCATGGTCTGGCTGCTGGCC
GCCTGCCTGGGCAGCGCAGCGGCTTTCGCGCAAACCGGCCCTGCAGCGCAGGCTGCTGCT
GCCGTGCAGCGCGTCGACGGCGATTTCATCCGCGCCAATGCCGCCAGGACGCCTGACTGG
CCCACCATCGGCGTGGACTATGCCGAGACCCGCTACAGCCGCCTCGATCAGATCAATGCC
GCCAACGTCAAGGACCTGGGCCTGGCATGGTCGTACAACCTCGAGTCCACGCGCGGCGTG
GAGGCCACGCCTGTCGTGGTGGACGGCATCATGTATGTCAGCGCCTCATGGAGCGTGGTG
CATGCCATCGACACCCGTACCGGCAACAGGATCTGGACCTATGACCCGCAGATCGACCGC
AGCACCGGCTTCAAGGGGTGCTGCGACGTCGTCAACCGCGGCGTGGCGCTGTGGAAGGGC
AAGGTCTATGTGGGGGCGTGGGATGGCCGCCTGATCGCGCTGGATGCCGCCACCGGCAAG
GAGGTCTGGCACCAAAATACCTTCGAGGGGCAGAAGGGGTCGCTCACCATCACCGGCGCC
CCGCGCGTGTTCAAGGGCAAGGTCATCATCGGCAAACGCGGCGCCGAATATGGCGTGCGC
GGCTATATCACTGCCTATGACGCCGAGACCGGGGAGCGGAAATGGCGCTGGTTCAGCGTA
CCCGGCGATCCCTCCAAACCCTTCGAGGACGAGTCCATGAAGCGCGCCGCCAGGACCTGG
GACCCCAGCGGCAAATGGTGGGAGGCCGGCGGCGGCGGCACCATGTGGGACAGCATGACC
TTCGATGCCGAACTCAACACCATGTACGTGGGCACGGGCAATGGATCGCCCTGGTCGCAC
AAGGTGCGCAGCCCCAAGGGCGGCGACAACCTGTACCTGGCCTCCATCGTGGCCCTGGAT
CCCGACACCGGCAAATACAAGTGGCACTATCAGGAAACACCGGGCGACAACTGGGACTAC
ACCTCCACCCAGCCCATGATCCTGGCCGACATCAAGATCGCCGGCAAGCCGCGCAAGGTC
ATACTGCATGCGCCCAAGAACGGCTTCTTCTTCGTGCTCGACCGCACCAATGGAAAGTTC
ATCTCGGCCAAGAACTTCGTGCCCGTGAACTGGGCCAGCGGCTACGACAAGCACGGCAAG
CCCATCGGCATTGCCGCAGCGCGCGACGGCAGCAAGCCCCAGGACGCGGTGCCGGGCCCC
TATGGCGCGCACAACTGGCACCCCATGTCCTTCAACCCCCAGACGGGCCTGGTGTATCTG
CCTGCGCAGAACGTGCCCGTCAACCTGATGGACGACAAGAAATGGGAGTTCAACCAGGCC
GGACCGGGCAAGCCCCAGTCGGGCACCGGCTGGAACACGGCCAAGTTCTTCAATGCCGAG
CCGCCCAAGAGCAAGCCCTTTGGTCGTCTGCTGGCCTGGGACCCCGTTGCGCAAAAGGCC
GCCTGGAGCGTGGAGCATGTCTCGCCCTGGAACGGCGGCACGCTGACCACGGCGGGCAAT
GTGGTGTTCCAGGGAACGGCTGATGGCCGCCTCGTGGCCTATCACGCGGCCACGGGCGAG
AAACTGTGGGAAGCGCCCACGGGCACCGGTGTGGTGGCCGCGCCCAGCACCTATATGGTG
GACGGCAGGCAGTATGTCTCGGTGGCCGTGGGCTGGGGCGGTGTCTACGGTCTGGCTGCG
CGCGCCACCGAGCGCCAGGGCCCGGGCACGGTCTATACCTTCGTCGTGGCCGGCAAGGCC
AGGATGCCGGAGTTCGTGGCCCAGCGCACCGGCCAGTTGCTGCAGGGCGTGAAATACGAC
CCCGCCAAGGTCGAGGCCGGCACCATGCTGTATGTGGCCAACTGCGTTTTCTGTCACGGC
GTGCCTGGCGTGGACCGTGGCGGAAACATTCCCAATCTGGGTTACATGGACGCGAGCTAT
ATCGAGAACCTGCCAAACTTTGTCTTCAAGGGCCCGGCCATGGTGCGCGGCATGCCGGAC
TTCACGGGCAAGTTGTCGGGCGATGACGTGGAGTCCCTCAAGGCCTTCATCCAGGGCACG
GCGGACGCCATCCGGCCCAAGCCCTGA

# Drug_Target_20_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_20_General_References:
11679760	Oubrie A, Huizinga EG, Rozeboom HJ, Kalk KH, de Jong GA, Duine JA, Dijkstra BW: Crystallization of quinohaemoprotein alcohol dehydrogenase from Comamonas testosteroni: crystals with unique optical properties. Acta Crystallogr D Biol Crystallogr. 2001 Nov;57(Pt 11):1732-4. Epub 2001 Oct 25.
11714714	Oubrie A, Rozeboom HJ, Kalk KH, Huizinga EG, Dijkstra BW: Crystal structure of quinohemoprotein alcohol dehydrogenase from Comamonas testosteroni: structural basis for substrate oxidation and electron transfer. J Biol Chem. 2002 Feb 1;277(5):3727-32. Epub 2001 Nov 19.
3521592	Groen BW, van Kleef MA, Duine JA: Quinohaemoprotein alcohol dehydrogenase apoenzyme from Pseudomonas testosteroni. Biochem J. 1986 Mar 15;234(3):611-5.
7601151	de Jong GA, Geerlof A, Stoorvogel J, Jongejan JA, de Vries S, Duine JA: Quinohaemoprotein ethanol dehydrogenase from Comamonas testosteroni. Purification, characterization, and reconstitution of the apoenzyme with pyrroloquinoline quinone analogues. Eur J Biochem. 1995 Jun 15;230(3):899-905.
8654419	Stoorvogel J, Kraayveld DE, Van Sluis CA, Jongejan JA, De Vries S, Duine JA: Characterization of the gene encoding quinohaemoprotein ethanol dehydrogenase of Comamonas testosteroni. Eur J Biochem. 1996 Feb 1;235(3):690-8.

# Drug_Target_20_HGNC_ID:
Not Available

# Drug_Target_20_HPRD_ID:
Not Available

# Drug_Target_20_ID:
3405

# Drug_Target_20_Locus:
Not Available

# Drug_Target_20_Molecular_Weight:
76823

# Drug_Target_20_Name:
Quinohaemoprotein ethanol dehydrogenase type-1

# Drug_Target_20_Number_of_Residues:
708

# Drug_Target_20_PDB_ID:
1KB0

# Drug_Target_20_Pathway:
Not Available

# Drug_Target_20_Pfam_Domain_Function:
PF01011	PQQ

# Drug_Target_20_Protein_Sequence:
>Quinohaemoprotein ethanol dehydrogenase type-1 precursor
MERLIDNSHGWPGRMVWLLAACLGSAAAFAQTGPAAQAAAAVQRVDGDFIRANAARTPDW
PTIGVDYAETRYSRLDQINAANVKDLGLAWSYNLESTRGVEATPVVVDGIMYVSASWSVV
HAIDTRTGNRIWTYDPQIDRSTGFKGCCDVVNRGVALWKGKVYVGAWDGRLIALDAATGK
EVWHQNTFEGQKGSLTITGAPRVFKGKVIIGKRGAEYGVRGYITAYDAETGERKWRWFSV
PGDPSKPFEDESMKRAARTWDPSGKWWEAGGGGTMWDSMTFDAELNTMYVGTGNGSPWSH
KVRSPKGGDNLYLASIVALDPDTGKYKWHYQETPGDNWDYTSTQPMILADIKIAGKPRKV
ILHAPKNGFFFVLDRTNGKFISAKNFVPVNWASGYDKHGKPIGIAAARDGSKPQDAVPGP
YGAHNWHPMSFNPQTGLVYLPAQNVPVNLMDDKKWEFNQAGPGKPQSGTGWNTAKFFNAE
PPKSKPFGRLLAWDPVAQKAAWSVEHVSPWNGGTLTTAGNVVFQGTADGRLVAYHAATGE
KLWEAPTGTGVVAAPSTYMVDGRQYVSVAVGWGGVYGLAARATERQGPGTVYTFVVAGKA
RMPEFVAQRTGQLLQGVKYDPAKVEAGTMLYVANCVFCHGVPGVDRGGNIPNLGYMDASY
IENLPNFVFKGPAMVRGMPDFTGKLSGDDVESLKAFIQGTADAIRPKP

# Drug_Target_20_Reaction:
Not Available

# Drug_Target_20_Signals:
1-31

# Drug_Target_20_Specific_Function:
Catalyzes the dye-linked oxidation of primary alcohols to the corresponding aldehydes and the (subsequent) oxidation of the aldehydes to carboxylic acids

# Drug_Target_20_SwissProt_ID:
Q46444

# Drug_Target_20_SwissProt_Name:
QHED_COMTE

# Drug_Target_20_Synonyms:
EC 1.1.99.-
QH-EDH1
Quinohaemoprotein ethanol dehydrogenase type I
Quinohaemoprotein ethanol dehydrogenase type-1 precursor

# Drug_Target_20_Theoretical_pI:
9.21

# Drug_Target_20_Transmembrane_Regions:
None

# Drug_Target_21_Cellular_Location:
Periplasm

# Drug_Target_21_Chromosome_Location:
Not Available

# Drug_Target_21_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_21_Essentiality:
Non-Essential

# Drug_Target_21_GenAtlas_ID:
Not Available

# Drug_Target_21_GenBank_ID_Gene:
U75413

# Drug_Target_21_GenBank_ID_Protein:
1654415

# Drug_Target_21_GeneCard_ID:
Not Available

# Drug_Target_21_Gene_Name:
nirS

# Drug_Target_21_Gene_Sequence:
>1791 bp
ATGAGACAAAGGACTCCATTCGCCAGACCCGGCCTCCTGGCCTCGGCAGCCCTGGCCCTT
GTCCTTGGACCGCTTGCGGCCGCGGCACAGGAACAGGTCGCCCCGCCAAAGGATCCAGCC
GCCGCGCTGGAGGACCACAAGACGCGCACCGACAATCGCTATGAGCCCTCGCTGGACAAC
CTTGCGCAGCAGGATGTCGCGGCTCCCGGGGCCCCCGAGGGTGTCACGGCCCTGTCCGAT
GCCCAATACAACGAGGCCAACAAGATCTATTTCGAACGCTGCGCCGGCTGCCACGGCGTG
TTGCGCAAAGGCGCGACCGGCAAGGCGCTGACCCCTGACCTGACCCGCGATCTGGGCTTT
GACTACCTGCAAAGCTTCATCACCTACGCCTCGCCGGCGGGGATGCCGAACTGGGGCACC
TCGGGCGAGTTGTCGGCCGAGCAGGTCGACCTGATGGCCAACTACCTGCTTCTGGACCCG
GCCGCGCCGCCGGAATTCGGCATGAAGGAGATGCGCGAATCCTGGAAGGTGCATGTCGCG
CCGGAAGACCGGCCGACCCAGCAGGAAAACGACTGGGATCTGGAAAACCTGTTCAGCGTC
ACCCTGCGCGACGCCGGCCAGATCGCGCTGATCGACGGCACCACCTATGAGATCAAGTCG
GTCCTCGACACCGGCTATGCGGTCCATATCAGCCGGCTGTCCGCATCGGGCCGCTACCTG
TTCGTGATCGGCCGCGACGGCAAGGTCAACATGATCGACCTGTGGATGAAGGAGCCCACC
ACCGTTGCCGAGATCAAGATCGGCTCGGAGGCGCGTTCCATCGAGACCTCGAAGATGGAG
GGCTGGGAGGACAAATACGCCATCGCCGGGGCCTATTGGCCGCCGCAATACGTCATCATG
GACGGCGAGACGCTGGAGCCGAAAAAGATCCAGTCCACGCGCGGCATGACCTATGACGAG
CAGGAATATCACCCCGAGCCGCGCGTCGCCGCGATCCTCGCCAGCCATTACCGGCCCGAG
TTCATCGTGAACGTCAAGGAAACGGGCAAGATCCTGCTGGTCGACTATACCGACCTCGAC
AACCTCAAGACCACCGAGATCAGCGCCGAACGCTTCCTGCACGACGGCGGCCTGGACGGC
TCGCACCGCTATTTCATCACCGCGGCGAACGCCCGCAACAAGCTGGTGGTGATCGACACC
AAGGAAGGCAAGCTGGTCGCGATCGAGGATACCGGCGGCCAGACCCCGCATCCGGGCCGC
GGCGCGAACTTCGTCCACCCGACCTTCGGGCCGGTCTGGGCGACCTCGCATATGGGCGAC
GATTCGGTGGCGCTGATCGGCACCGATCCCGAGGGCCATCCCGACAATGCCTGGAAGATC
CTCGACAGCTTCCCGGCGTTGGGGGGCGGCTCGCTGTTCATCAAGACGCACCCGAACTCG
CAATATCTCTATGTCGATGCGACCCTGAACCCCGAGGCCGAGATTTCCGGCTCGGTCGCG
GTGTTCGACATCAAGGCGATGACGGGCGACGGTTCGGACCCCGAGTTCAAGACCCTGCCC
ATCGCCGAATGGGCCGGCATCACCGAAGGCCAGCCCCGCGTCGTGCAGGGCGAGTTCAAC
AAGGACGGCACCGAGGTCTGGTTCAGCGTCTGGAACGGCAAGGACCAGGAATCGGCGCTG
GTCGTGGTGGACGACAAGACGCTGGAACTTAAGCACGTCATCAAGGACGAGCGGCTGGTG
ACGCCCACCGGCAAGTTCAACGTCTACAACACCATGACCGACACCTATTGA

# Drug_Target_21_General_Function:
Energy production and conversion

# Drug_Target_21_General_References:
10708389	Saunders NF, Ferguson SJ, Baker SC: Transcriptional analysis of the nirS gene, encoding cytochrome cd1 nitrite reductase, of Paracoccus pantotrophus LMD 92.63. Microbiology. 2000 Feb;146 ( Pt 2):509-16.
10827177	Jafferji A, Allen JW, Ferguson SJ, Fulop V: X-ray crystallographic study of cyanide binding provides insights into the structure-function relationship for cytochrome cd1 nitrite reductase from Paracoccus pantotrophus. J Biol Chem. 2000 Aug 18;275(33):25089-94.
10998233	Sjogren T, Svensson-Ek M, Hajdu J, Brzezinski P: Proton-coupled structural changes upon binding of carbon monoxide to cytochrome cd1: a combined flash photolysis and X-ray crystallography study. Biochemistry. 2000 Sep 12;39(36):10967-74.
11237728	Gordon EH, Steensma E, Ferguson SJ: The cytochrome c domain of dimeric cytochrome cd(1) of Paracoccus pantotrophus can be produced at high levels as a monomeric holoprotein using an improved c-type cytochrome expression system in Escherichia coli. Biochem Biophys Res Commun. 2001 Mar 2;281(3):788-94.
11278884	Sjogren T, Hajdu J: Structure of the bound dioxygen species in the cytochrome oxidase reaction of cytochrome cd1 nitrite reductase. J Biol Chem. 2001 Apr 20;276(16):13072-6. Epub 2001 Jan 26.
11373294	Sjogren T, Hajdu J: The Structure of an alternative form of Paracoccus pantotrophus cytochrome cd(1) nitrite reductase. J Biol Chem. 2001 Aug 3;276(31):29450-5. Epub 2001 May 23.
7736589	Fulop V, Moir JW, Ferguson SJ, Hajdu J: The anatomy of a bifunctional enzyme: structural basis for reduction of oxygen to water and synthesis of nitric oxide by cytochrome cd1. Cell. 1995 May 5;81(3):369-77.
9199411	Baker SC, Saunders NF, Willis AC, Ferguson SJ, Hajdu J, Fulop V: Cytochrome cd1 structure: unusual haem environments in a nitrite reductase and analysis of factors contributing to beta-propeller folds. J Mol Biol. 1997 Jun 13;269(3):440-55.
9311786	Williams PA, Fulop V, Garman EF, Saunders NF, Ferguson SJ, Hajdu J: Haem-ligand switching during catalysis in crystals of a nitrogen-cycle enzyme. Nature. 1997 Sep 25;389(6649):406-12.

# Drug_Target_21_HGNC_ID:
Not Available

# Drug_Target_21_HPRD_ID:
Not Available

# Drug_Target_21_ID:
3284

# Drug_Target_21_Locus:
Not Available

# Drug_Target_21_Molecular_Weight:
65384

# Drug_Target_21_Name:
Nitrite reductase

# Drug_Target_21_Number_of_Residues:
596

# Drug_Target_21_PDB_ID:
1HCM

# Drug_Target_21_Pathway:
Not Available

# Drug_Target_21_Pfam_Domain_Function:
PF00034	Cytochrom_C
PF02239	Cytochrom_D1

# Drug_Target_21_Protein_Sequence:
>Nitrite reductase precursor
MRQRTPFARPGLLASAALALVLGPLAASAQEQVAPPKDPAAALEDHKTRTDNRYEPSLDN
LAQQDVAAPGAPEGVSALSDAQYNEANKIYFERCAGCHGVLRKGATGKALTPDLTRDLGF
DYLQSFITYGSPAGMPNWGTSGELSAEQVDLMANYLLLDPAAPPEFGMKEMRESWKVHVA
PEDRPTQQENDWDLENLFSVTLRDAGQIALIDGATYEIKSVLDTGYAVHISRLSASGRYL
FVIGRDGKVNMIDLWMKEPTTVAEIKIGSEARSIETSKMEGWEDKYAIAGAYWPPQYVIM
DGETLEPKKIQSTRGMTYDEQEYHPEPRVAAILASHYRPEFIVNVKETGKILLVDYTDLD
NLKTTEISAERFLHDGGLDGSHRYFITAANARNKLVVIDTKEGKLVAIEDTGGQTPHPGR
GANFVHPTFGPVWATSHMGDDSVALIGTDPEGHPDNAWKILDSFPALGGGSLFIKTHPNS
QYLYVDATLNPEAEISGSVAVFDIKAMTGDGSDPEFKTLPIAEWAGITEGQPRVVQGEFN
KDGTEVWFSVWNGKDQESALVVVDDKTLELKHVIKDERLVTPTGKFNVYNTMTDTY

# Drug_Target_21_Reaction:
nitric oxide + H2O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H+

# Drug_Target_21_Signals:
1-29

# Drug_Target_21_Specific_Function:
Nitric oxide + H(2)O + ferricytochrome c = nitrite + ferrocytochrome c + 2 H(+)

# Drug_Target_21_SwissProt_ID:
P72181

# Drug_Target_21_SwissProt_Name:
NIRS_PARPN

# Drug_Target_21_Synonyms:
Cytochrome cd1
Cytochrome oxidase
EC 1.7.2.1
EC 1.7.99.1
Hydroxylamine reductase
Nitrite reductase precursor

# Drug_Target_21_Theoretical_pI:
4.59

# Drug_Target_21_Transmembrane_Regions:
None

# Drug_Target_22_Cellular_Location:
Periplasm

# Drug_Target_22_Chromosome_Location:
Not Available

# Drug_Target_22_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_22_Essentiality:
Non-Essential

# Drug_Target_22_GenAtlas_ID:
Not Available

# Drug_Target_22_GenBank_ID_Gene:
U05988

# Drug_Target_22_GenBank_ID_Protein:
516878

# Drug_Target_22_GeneCard_ID:
Not Available

# Drug_Target_22_Gene_Name:
cc4

# Drug_Target_22_Gene_Sequence:
>633 bp
ATGAACAAAGTACTCGTGAGTCTGCTGTTGACCCTTGGCATCACCGGTATGGCCCACGCG
GCTGGAGACGCCGAAGCTGGTCAGGGCAAAGTTGCAGTGTGTGGTGCGTGCCACGGTGTC
GATGGCAACAGCCCGGCGCCGAATTTCCCGAAACTGGCTGGCCAGGGTGAGCGTTACCTG
CTCAAGCAACTGCAGGACATCAAGGCTGGCAGCACACCGGGTGCCCCGGAAGGCGTAGGT
CGCAAGGTGTTGGAAATGACCGGCATGCTGGACCCGCTGAGTGATCAGGATCTGGAAGAC
ATCGCCGCCTACTTCTCAAGCCAGAAGGGCAGTGTTGGTTACGCCGATCCGGCTCTGGCA
AAGCAGGGCGAGAAACTGTTCCGTGGTGGCAAGCTCGATCAGGGCATGCCGGCGTGCACC
GGTTGCCACGCACCCAACGGCGTCGGTAACGACCTGGCTGGCTTCCCCAAGCTGGGTGGG
CAGCACGCGGCGTACACCGCCAAGCAGCTGACCGACTTCCGCGAAGGCAATCGCACCAAC
GACGGCGACACCATGATCATGCGTGGCGTCGCCGCCAAGCTGAGCAACAAGGACATCGAA
GCGCTGTCCAGCTACATCCAGGGCCTGCACTGA

# Drug_Target_22_General_Function:
Energy production and conversion

# Drug_Target_22_General_References:
8026750	Christensen HE: Cloning and characterisation of the gene encoding cytochrome c4 from Pseudomonas stutzeri. Gene. 1994 Jun 24;144(1):139-40.
9032080	Kadziola A, Larsen S: Crystal structure of the dihaem cytochrome c4 from Pseudomonas stutzeri determined at 2.2A resolution. Structure. 1997 Feb 15;5(2):203-16.

# Drug_Target_22_HGNC_ID:
Not Available

# Drug_Target_22_HPRD_ID:
Not Available

# Drug_Target_22_ID:
3221

# Drug_Target_22_Locus:
Not Available

# Drug_Target_22_Molecular_Weight:
21742

# Drug_Target_22_Name:
Cytochrome c4

# Drug_Target_22_Number_of_Residues:
210

# Drug_Target_22_PDB_ID:
1M70

# Drug_Target_22_Pathway:
Not Available

# Drug_Target_22_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_22_Protein_Sequence:
>Cytochrome c4 precursor
MNKVLVSLLLTLGITGMAHAAGDAEAGQGKVAVCGACHGVDGNSPAPNFPKLAGQGERYL
LKQLQDIKAGSTPGAPEGVGRKVLEMTGMLDPLSDQDLEDIAAYFSSQKGSVGYADPALA
KQGEKLFRGGKLDQGMPACTGCHAPNGVGNDLAGFPKLGGQHAAYTAKQLTDFREGNRTN
DGDTMIMRGVAAKLSNKDIEALSSYIQGLH

# Drug_Target_22_Reaction:
Not Available

# Drug_Target_22_Signals:
1-20

# Drug_Target_22_Specific_Function:
Diheme, high potential cytochrome c believed to be an intermediate electron donor to terminal oxidation systems

# Drug_Target_22_SwissProt_ID:
Q52369

# Drug_Target_22_SwissProt_Name:
CYC4_PSEST

# Drug_Target_22_Synonyms:
Cytochrome c4 precursor

# Drug_Target_22_Theoretical_pI:
6.67

# Drug_Target_22_Transmembrane_Regions:
None

# Drug_Target_23_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_23_Chromosome_Location:
Not Available

# Drug_Target_23_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_23_Essentiality:
Non-Essential

# Drug_Target_23_GenAtlas_ID:
CYCS

# Drug_Target_23_GenBank_ID_Gene:
M22877

# Drug_Target_23_GenBank_ID_Protein:
181242

# Drug_Target_23_GeneCard_ID:
CYCS

# Drug_Target_23_Gene_Name:
CYCS

# Drug_Target_23_Gene_Sequence:
>318 bp
ATGGGTGATGTTGAGAAAGGCAAGAAGATTTTTATTATGAAGTGTTCCCAGTGCCACACC
GTTGAAAAGGGAGGCAAGCACAAGACTGGGCCAAATCTCCATGGTCTCTTTGGGCGGAAG
ACAGGTCAGGCCCCTGGATACTCTTACACAGCCGCCAATAAGAACAAAGGCATCATCTGG
GGAGAGGATACACTGATGGAGTATTTGGAGAATCCCAAGAAGTACATCCCTGGAACAAAA
ATGATCTTTGTCGGCATTAAGAAGAAGGAAGAAAGGGCAGACTTAATAGCTTATCTCAAA
AAAGCTACTAATGAGTAA

# Drug_Target_23_General_Function:
Energy production and conversion

# Drug_Target_23_General_References:
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
2849112	Evans MJ, Scarpulla RC: The human somatic cytochrome c gene: two classes of processed pseudogenes demarcate a period of rapid molecular evolution. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9625-9.
9515723	Skulachev VP: Cytochrome c in the apoptotic and antioxidant cascades. FEBS Lett. 1998 Feb 27;423(3):275-80.

# Drug_Target_23_HGNC_ID:
HGNC:19986

# Drug_Target_23_HPRD_ID:
00479

# Drug_Target_23_ID:
1507

# Drug_Target_23_Locus:
7p15.2

# Drug_Target_23_Molecular_Weight:
11749

# Drug_Target_23_Name:
Cytochrome c

# Drug_Target_23_Number_of_Residues:
105

# Drug_Target_23_PDB_ID:
1J3S

# Drug_Target_23_Pathway:
Not Available

# Drug_Target_23_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_23_Protein_Sequence:
>Cytochrome c
MGDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIW
GEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE

# Drug_Target_23_Reaction:
Not Available

# Drug_Target_23_Signals:
None

# Drug_Target_23_Specific_Function:
Plays a role in apoptosis. Suppression of the anti- apoptotic members or activation of the pro-apoptotic members of the Bcl-2 family leads to altered mitochondrial membrane permeability resulting in release of cytochrome c into the cytosol. Binding of cytochrome c to Apaf-1 triggers the activation of caspase-9, which then accelerates apoptosis by activating other caspases

# Drug_Target_23_SwissProt_ID:
P99999

# Drug_Target_23_SwissProt_Name:
CYC_HUMAN

# Drug_Target_23_Synonyms:
Not Available

# Drug_Target_23_Theoretical_pI:
10.16

# Drug_Target_23_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
BX572597

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
cycA

# Drug_Target_2_Gene_Sequence:
>420 bp
TTACTTGAGGGTGGCCAGATAGGCGACCACGTCCTTACGCTGCTGCTCGTTGGCGAGCTT
GAAGGTCATCTTGGTGACACCGACCGCCTGATCAGCCTTACCCTTATCGGTCAGGAACTT
CTTCAGGAACGCGTTCGGATCGTTCAGGTAGTTGATGATGTTGTCGGCGGTCCAGACCAG
ACCCGCTTCACCCGAATTGTGGTTCAGCGGCGAATAGGTGAAGCCAGCCGCGGTACCGGC
CTTACGACCGACGACGCCGCCCAGAGCCGGACCGACCATGTTCTTGTCGGCGCGGTGGCA
GGTCATGCACTGTTTGAACACCGCCTCACCCGCCTTGGCGTCCTGGGCCGAGGCAGTGCC
GATCGACAGAGATCCGGCGGTAGCGGCGATGCTGAGAATTGTGAGAAGTTTTTTGACCAC

# Drug_Target_2_General_Function:
Involved in iron ion binding

# Drug_Target_2_General_References:
221822	Ambler RP, Daniel M, Hermoso J, Meyer TE, Bartsch RG, Kamen MD: Cytochrome c2 sequence variation among the recognised species of purple nonsulphur photosynthetic bacteria. Nature. 1979 Apr 12;278(5705):659-60.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4964

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
14633

# Drug_Target_2_Name:
Cytochrome c2

# Drug_Target_2_Number_of_Residues:
139

# Drug_Target_2_PDB_ID:
1I8P

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_2_Protein_Sequence:
>Cytochrome c2
MVKKLLTILSIAATAGSLSIGTASAQDAKAGEAVFKQCMTCHRADKNMVGPALGGVVGRK
AGTAAGFTYSPLNHNSGEAGLVWTADNIINYLNDPNAFLKKFLTDKGKADQAVGVTKMTF
KLANEQQRKDVVAYLATLK

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-25

# Drug_Target_2_Specific_Function:
Cytochrome c2 is found mainly in purple, non-sulfur, photosynthetic bacteria where it functions as the electron donor to the oxidized bacteriochlorophyll in the photophosphorylation pathway. However, it may also have a role in the respiratory chain and is found in some non-photosynthetic bacteria

# Drug_Target_2_SwissProt_ID:
P00091

# Drug_Target_2_SwissProt_Name:
CYC22_RHOPA

# Drug_Target_2_Synonyms:
Cytochrome c2 precursor

# Drug_Target_2_Theoretical_pI:
10.14

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cellular thylakoid membrane

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
Not Available

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
D45178

# Drug_Target_3_GenBank_ID_Protein:
Not Available

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
psbV

# Drug_Target_3_Gene_Sequence:
>483 bp
GTGAAACGCTTTTTTCTGGTGGCGATCGCCTCTGTCCTATTTTTCTTTAACACCATGGTC
GGCAGTGCCAATGCGGTGGAGTTAACCGAAAGCACCCGCACCATTCCCCTCGATGAAGCC
GGTGGCACCACAACCTTAACCGCCCGCCAGTTCACCAACGGCCAAAAGATTTTTGTGGAC
ACCTGCACCCAATGTCACCTCCAGGGTAAAACCAAAACTAATAATAACGTTAGTTTAGGC
TTGGCAGACTTGGCTGGTGCCGAGCCCCGTCGGGACAACGTCCTGGCCTTGGTGGAATTT
CTCAAGAATCCCAAGAGTTATGACGGTGAAGATGACTATTCGGAATTACATCCCAATATT
TCCCGTCCCGACATCTACCCAGAAATGAGAAACTACACCGAAGACGACATCTTTGATGTG
GCTGGTTACACCCTCATTGCTCCCAAATTAGATGAACGGTGGGGTGGCACCATCTACTTC
TAG

# Drug_Target_3_General_Function:
Involved in iron ion binding

# Drug_Target_3_General_References:
7896839	Shen JR, Vermaas W, Inoue Y: The role of cytochrome c-550 as studied through reverse genetics and mutant characterization in Synechocystis sp. PCC 6803. J Biol Chem. 1995 Mar 24;270(12):6901-7.
8181563	Kang C, Chitnis PR, Smith S, Krogmann DW: Cloning and sequence analysis of the gene encoding the low potential cytochrome c of Synechocystis PCC 6803. FEBS Lett. 1994 May 9;344(1):5-9.
8905231	Kaneko T, Sato S, Kotani H, Tanaka A, Asamizu E, Nakamura Y, Miyajima N, Hirosawa M, Sugiura M, Sasamoto S, Kimura T, Hosouchi T, Matsuno A, Muraki A, Nakazaki N, Naruo K, Okumura S, Shimpo S, Takeuchi C, Wada T, Watanabe A, Yamada M, Yasuda M, Tabata S: Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res. 1996 Jun 30;3(3):109-36.
9298645	Sazuka T, Ohara O: Towards a proteome project of cyanobacterium Synechocystis sp. strain PCC6803: linking 130 protein spots with their respective genes. Electrophoresis. 1997 Aug;18(8):1252-8.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
5216

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
17884

# Drug_Target_3_Name:
Cytochrome c-550

# Drug_Target_3_Number_of_Residues:
160

# Drug_Target_3_PDB_ID:
1E29

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_3_Protein_Sequence:
>Cytochrome c-550
MKRFFLVAIASVLFFFNTMVGSANAVELTESTRTIPLDEAGGTTTLTARQFTNGQKIFVD
TCTQCHLQGKTKTNNNVSLGLADLAGAEPRRDNVLALVEFLKNPKSYDGEDDYSELHPNI
SRPDIYPEMRNYTEDDIFDVAGYTLIAPKLDERWGGTIYF

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
1-25

# Drug_Target_3_Specific_Function:
Low-potential cytochrome c that plays a role in the water oxidation complex of photosystem II. Required for normal function or stabilization of photosystem II. Extrinsic protein associated with photosystem II that enhances oxygen evolution

# Drug_Target_3_SwissProt_ID:
Q55013

# Drug_Target_3_SwissProt_Name:
CY550_SYNY3

# Drug_Target_3_Synonyms:
Cytochrome c-550 precursor
Cytochrome c550
Low-potential cytochrome c

# Drug_Target_3_Theoretical_pI:
4.54

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cell membrane

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
Not Available

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
X70367

# Drug_Target_4_GenBank_ID_Protein:
Not Available

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
cycM

# Drug_Target_4_Gene_Sequence:
>531 bp
ATGTTCGATACCATGACCGTCACCAAGGCAGCCGGTGCGCTGATCGGCTCGCTTCTGTTC
CTTCTGCTGATGAGCTGGGCGGCATCGGGTATCTTTCACGTCGGCACCTCGGGCCACGGC
GCCGAGGGCGAAGAGCATGCCCAGGCATATACCTACCCGGTCGAGAGCGCCGGCGGCGCC
GAGGGCGAGGCCGTGGACGAAGGCCCCGATTTTGCCACCGTCCTGGCCTCGGCCGATCCC
GCCGCTGGCGAGAAGGTGTTCGGCAAGTGCAAGGCCTGCCACAAGCTGGACGGCAACGAT
GGCGTCGGCCCGCATCTGAACGGCGTCGTCGGCCGCACGGTCGCAGGCGTCGATGGCTTC
AACTATTCCGACCCGATGAAGGCGCATGGCGGCGACTGGACCCCCGAGGCGCTGCAGGAA
TTCCTGACCAACCCGAAAGCGGTGGTCAAGGGCACCAAAATGGCCTTCGCCGGCCTGCCC
AAGATCGAGGATCGCGCCAACCTGATCGCCTATCTGGAAGGCCAGCAGTAA

# Drug_Target_4_General_Function:
Involved in iron ion binding

# Drug_Target_4_General_References:
7628479	Turba A, Jetzek M, Ludwig B: Purification of Paracoccus denitrificans cytochrome c552 and sequence analysis of the gene. Eur J Biochem. 1995 Jul 1;231(1):259-65.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
5217

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
18210

# Drug_Target_4_Name:
Cytochrome c-552

# Drug_Target_4_Number_of_Residues:
176

# Drug_Target_4_PDB_ID:
1I6E

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_4_Protein_Sequence:
>Cytochrome c-552
MFDTMTVTKAAGALIGSLLFLLLMSWAASGIFHVGTSGHGAEGEEHAQAYTYPVESAGGA
EGEAVDEGPDFATVLASADPAAGEKVFGKCKACHKLDGNDGVGPHLNGVVGRTVAGVDGF
NYSDPMKAHGGDWTPEALQEFLTNPKAVVKGTKMAFAGLPKIEDRANLIAYLEGQQ

# Drug_Target_4_Reaction:
Not Available

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Mediates the electron transport between the cytochrome bc1 complex and cytochrome-c oxidase

# Drug_Target_4_SwissProt_ID:
P54820

# Drug_Target_4_SwissProt_Name:
CY552_PARDE

# Drug_Target_4_Synonyms:
Cytochrome c552

# Drug_Target_4_Theoretical_pI:
4.67

# Drug_Target_4_Transmembrane_Regions:
12-32

# Drug_Target_5_Cellular_Location:
Periplasm

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
Not Available

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
X56813

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
nirM

# Drug_Target_5_Gene_Sequence:
>315 bp
ATGAAAAAAATTCTAATCCCGATGCTCGCCCTCGGCGGCGCGCTGGCCATGCAGCCGGCG
CTGGCGCAAGACGGTGAAGCGCTGTTCAAGAGCAAGCCTTGCGCGGCCTGCCACAGCGTC
GACACCAAGATGGTTGGCCCGGCTCTGAAAGAAGTCGCCGCCAAGAATGCCGGCGTCGAA
GGCGCTGCCGACACCCTGGCTCTGCACATCAAGAATGGCAGCCAAGGCGTTTGGGGCCCG
ATCCCGATGCCGCCAAACCCAGTCACCGAGGAGGAAGCCAAGATCCTCGCCGAGTGGGTT
CTTAGCCTCAAGTAA

# Drug_Target_5_General_Function:
Involved in iron ion binding

# Drug_Target_5_General_References:
1327105	Cai M, Bradford EG, Timkovich R: Investigation of the solution conformation of cytochrome c-551 from Pseudomonas stutzeri. Biochemistry. 1992 Sep 15;31(36):8603-12.
2001732	Jungst A, Wakabayashi S, Matsubara H, Zumft WG: The nirSTBM region coding for cytochrome cd1-dependent nitrite respiration of Pseudomonas stutzeri consists of a cluster of mono-, di-, and tetraheme proteins. FEBS Lett. 1991 Feb 25;279(2):205-9.
4352718	Ambler RP, Wynn M: The amino acid sequences of cytochromes c-551 from three species of Pseudomonas. Biochem J. 1973 Mar;131(3):485-98.
7811935	Cai M, Timkovich R: Solution conformation of cytochrome c-551 from Pseudomonas stutzeri ZoBell determined by NMR. Biophys J. 1994 Sep;67(3):1207-15.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
5218

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
10797

# Drug_Target_5_Name:
Cytochrome c-551

# Drug_Target_5_Number_of_Residues:
104

# Drug_Target_5_PDB_ID:
1CCH

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_5_Protein_Sequence:
>Cytochrome c-551
MKKILIPMLALGGALAMQPALAQDGEALFKSKPCAACHSVDTKMVGPALKEVAAKNAGVE
GAADTLALHIKNGSQGVWGPIPMPPNPVTEEEAKILAEWVLSLK

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
1-22

# Drug_Target_5_Specific_Function:
Electron donor for cytochrome cd1 in nitrite and nitrate respiration

# Drug_Target_5_SwissProt_ID:
P00101

# Drug_Target_5_SwissProt_Name:
CY551_PSEST

# Drug_Target_5_Synonyms:
Cytochrome C8
Cytochrome c-551 precursor
Cytochrome c551

# Drug_Target_5_Theoretical_pI:
7.42

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
AF005234

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
cyd

# Drug_Target_6_Gene_Sequence:
>207 bp
GCTGATGTGGTGACGTATGAGAATAAGAAGGGCAACGTTACCTTTGACCACAAAGCTCAT
GCCGAGAAACTGGGCTGTGACGCATGTCACGAAGGTACTCCGGCAAAGATTGCTATCGAC
AAGAAGTCTGCTCACAAAGACGCGTGCAAAACCTGCCACAAAAGCAACAATGGCCCCACC
AAATGTGGCGGCTGCCATATCAAATAG

# Drug_Target_6_General_Function:
Involved in iron ion binding

# Drug_Target_6_General_References:
10561607	Assfalg M, Banci L, Bertini I, Bruschi M, Giudici-Orticoni MT, Turano P: A proton-NMR investigation of the fully reduced cytochrome c7 from Desulfuromonas acetoxidans. Comparison between the reduced and the oxidized forms. Eur J Biochem. 1999 Dec;266(2):634-43.
11320307	Czjzek M, Arnoux P, Haser R, Shepard W: Structure of cytochrome c7 from Desulfuromonas acetoxidans at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr. 2001 May;57(Pt 5):670-8. Epub 2001 Apr 24.
11883773	Assfalg M, Bertini I, Turano P, Bruschi M, Durand MC, Giudici-Orticoni MT, Dolla A: A quick solution structure determination of the fully oxidized double mutant K9-10A cytochrome c7 from Desulfuromonas acetoxidans and mechanistic implications. J Biomol NMR. 2002 Feb;22(2):107-22.
12119407	Assfalg M, Bertini I, Bruschi M, Michel C, Turano P: The metal reductase activity of some multiheme cytochromes c: NMR structural characterization of the reduction of chromium(VI) to chromium(III) by cytochrome c(7). Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9750-4. Epub 2002 Jul 15.
8962062	Banci L, Bertini I, Bruschi M, Sompornpisut P, Turano P: NMR characterization and solution structure determination of the oxidized cytochrome c7 from Desulfuromonas acetoxidans. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14396-400.
9030775	Turner DL, Costa HS, Coutinho IB, Legall J, Xavier AV: Assignment of the ligand geometry and redox potentials of the trihaem ferricytochrome c3 from Desulfuromonas acetoxidans. Eur J Biochem. 1997 Jan 15;243(1-2):474-81.
9760163	Assfalg M, Banci L, Bertini I, Bruschi M, Turano P: 800 MHz 1H NMR solution structure refinement of oxidized cytochrome c7 from Desulfuromonas acetoxidans. Eur J Biochem. 1998 Sep 1;256(2):261-70.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
5219

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
7262

# Drug_Target_6_Name:
Cytochrome c3

# Drug_Target_6_Number_of_Residues:
68

# Drug_Target_6_PDB_ID:
1HH5

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
Not Available

# Drug_Target_6_Protein_Sequence:
>Cytochrome c3
ADVVTYENKKGNVTFDHKAHAEKLGCDACHEGTPAKIAIDKKSAHKDACKTCHKSNNGPT
KCGGCHIK

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Participates in sulfate respiration coupled with phosphorylation by transferring electrons from the enzyme dehydrogenase to ferredoxin

# Drug_Target_6_SwissProt_ID:
P00137

# Drug_Target_6_SwissProt_Name:
CYC3_DESAC

# Drug_Target_6_Synonyms:
Cytochrome c551.5
Cytochrome c7

# Drug_Target_6_Theoretical_pI:
8.62

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
Not Available

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
Not Available

# Drug_Target_7_GenBank_ID_Protein:
Not Available

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
Ddes_2150

# Drug_Target_7_Gene_Sequence:
Not Available

# Drug_Target_7_General_Function:
Not Available

# Drug_Target_7_General_References:
1646022	Moura JJ, Costa C, Liu MY, Moura I, LeGall J: Structural and functional approach toward a classification of the complex cytochrome c system found in sulfate-reducing bacteria. Biochim Biophys Acta. 1991 May 23;1058(1):61-6.
9346301	Devreese B, Costa C, Demol H, Papaefthymiou V, Moura I, Moura JJ, Van Beeumen J: The primary structure of the split-Soret cytochrome c from Desulfovibrio desulfuricans ATCC 27774 reveals an unusual type of diheme cytochrome c. Eur J Biochem. 1997 Sep 1;248(2):445-51.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
5220

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
26937

# Drug_Target_7_Name:
Split-Soret cytochrome c

# Drug_Target_7_Number_of_Residues:
247

# Drug_Target_7_PDB_ID:
1H21

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
Not Available

# Drug_Target_7_Protein_Sequence:
>Split-Soret cytochrome c
GEAQPASGRFDQVGGAFGWKPHKLDPKECAQVAYDGYWYKGFGCGFGAFYSIVGLMGEKY
GAPYNQFPFAMLEANKGGISDWGTIYGALYGAAATFSLFWGRKEVHPMVNELFRWYEVTK
LPIFNPGDAAQGVKGDLPMSASDSVLCHISVSKWCYENKIEATSKQRSERAGRLTADAAF
KAAEIINTKIDQGKDFKSTFPMQASVSSCGECHMTKGNDANWAKGIMDCTPCHSGTAATQ
NKFVNHP

# Drug_Target_7_Reaction:
Not Available

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Diheme cytochrome c which may be involved in sulfate reduction

# Drug_Target_7_SwissProt_ID:
P81040

# Drug_Target_7_SwissProt_Name:
CYCX_DESDA

# Drug_Target_7_Synonyms:
Not Available

# Drug_Target_7_Theoretical_pI:
7.73

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
Not Available

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
BX842577

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
glbN

# Drug_Target_8_Gene_Sequence:
>411 bp
TCAGACTGGTGCCGTGGTGCTCTCGCCCGATGTGACGTCGACCGCCAGCGGCGCGATGAC
GCCGAGGATTTCCGTGATCGTTTCGGAGGGCACGCCGGCTGCGGTCAGCGCGTCGGCCAA
GTGTCCGGCGACCAGGCTGAAGTGGTGCATGGTAATTCCGCGCCCCTGATGGACTTGCTT
CATCGGCGCACCGGTATAGGGCTCGGGCCCGCCAAGCGCGGCCGCGAAAAACTCCACCTG
CTTGCCCTTGAGGCGGCTCATGTTCGTACCGCTGAAGAAGGCCGATAGTTGGTCATCGGC
AAGCACACGAACATAGAAGTCCTCGACGACGACTTCGATGGCCTCATGCCCGCCGATCTT
GTCGTAGATGCTGATCGGCTCACGTTTGCGCAAGCGTGACAGTAGTCCCAT

# Drug_Target_8_General_Function:
Involved in oxygen binding

# Drug_Target_8_General_References:
10636862	Yeh SR, Couture M, Ouellet Y, Guertin M, Rousseau DL: A cooperative oxygen binding hemoglobin from Mycobacterium tuberculosis. Stabilization of heme ligands by a distal tyrosine residue. J Biol Chem. 2000 Jan 21;275(3):1679-84.
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
4386

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
14449

# Drug_Target_8_Name:
Hemoglobin-like protein HbN

# Drug_Target_8_Number_of_Residues:
136

# Drug_Target_8_PDB_ID:
1RTE

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF01152	Bac_globin

# Drug_Target_8_Protein_Sequence:
>Hemoglobin-like protein HbN
MGLLSRLRKREPISIYDKIGGHEAIEVVVEDFYVRVLADDQLSAFFSGTNMSRLKGKQVE
FFAAALGGPEPYTGAPMKQVHQGRGITMHHFSLVAGHLADALTAAGVPSETITEILGVIA
PLAVDVTSGESTTAPV

# Drug_Target_8_Reaction:
Not Available

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Binds oxygen cooperatively with very high affinity (P(50) = 0.013 mmHg at 20 degrees Celsius) because of a fast combination (25 microM(-1).s(-1)) and a slow dissociation (0.2 s(- 1)) rate

# Drug_Target_8_SwissProt_ID:
P0A592

# Drug_Target_8_SwissProt_Name:
TRHBN_MYCTU

# Drug_Target_8_Synonyms:
Flavohemoglobin
Truncated hemoglobin
trHbN

# Drug_Target_8_Theoretical_pI:
5.98

# Drug_Target_8_Transmembrane_Regions:
None

# Drug_Target_9_Cellular_Location:
Cell membrane

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
Not Available

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
Not Available

# Drug_Target_9_GenBank_ID_Gene:
Not Available

# Drug_Target_9_GenBank_ID_Protein:
Not Available

# Drug_Target_9_GeneCard_ID:
Not Available

# Drug_Target_9_Gene_Name:
Not Available

# Drug_Target_9_Gene_Sequence:
Not Available

# Drug_Target_9_General_Function:
Involved in iron ion binding

# Drug_Target_9_General_References:
10529373	Vandenberghe IH, Guisez Y, Ciurli S, Benini S, Van Beeumen JJ: Cytochrome c-553 from the alkalophilic bacterium Bacillus pasteurii has the primary structure characteristics of a lipoprotein. Biochem Biophys Res Commun. 1999 Oct 22;264(2):380-7.

# Drug_Target_9_HGNC_ID:
Not Available

# Drug_Target_9_HPRD_ID:
Not Available

# Drug_Target_9_ID:
4948

# Drug_Target_9_Locus:
Not Available

# Drug_Target_9_Molecular_Weight:
8991

# Drug_Target_9_Name:
Cytochrome c-553

# Drug_Target_9_Number_of_Residues:
92

# Drug_Target_9_PDB_ID:
1N9C

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00034	Cytochrom_C

# Drug_Target_9_Protein_Sequence:
>Cytochrome c-553
GGGNDTSNETDTGTSGGETAAVDAEAVVQQKCISCHGGDLTGASAPAIDKAGANYSEEEI
LDIILNGQGGMPGGIAKGAEAEAVAAWLAEKK

# Drug_Target_9_Reaction:
Not Available

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Natural electron acceptor for a formate dehydrogenase

# Drug_Target_9_SwissProt_ID:
P82599

# Drug_Target_9_SwissProt_Name:
CY553_BACPA

# Drug_Target_9_Synonyms:
Cytochrome c553

# Drug_Target_9_Theoretical_pI:
3.88

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03317
